|
OMIM |
Link |
Information gain |
01 |
|
RA
|
[NCBI]
|
0.00377623
|
|
|
SLE
|
[NCBI]
|
0.00245379
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.00147621
|
|
|
CCA1
|
[NCBI]
|
0.00127799
|
|
|
HMN1
|
[NCBI]
|
0.00120842
|
|
|
holoprosencephaly
|
[NCBI]
|
0.00119417
|
|
|
SCA23
|
[NCBI]
|
0.000999951
|
|
|
BMND7
|
[NCBI]
|
0.000999951
|
|
|
CF
|
[NCBI]
|
0.000988973
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.000735752
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.000636665
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
0.000636665
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000636665
|
|
|
migraine without aura, susceptibility to, 4
|
[NCBI]
|
0.000636665
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.000636665
|
|
|
EXT3
|
[NCBI]
|
0.000572675
|
|
|
ALS5
|
[NCBI]
|
0.000572675
|
|
|
ALSFTD1
|
[NCBI]
|
0.000572675
|
|
|
ARVD5
|
[NCBI]
|
0.000572675
|
|
|
CTAA2
|
[NCBI]
|
0.000572675
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000572675
|
|
|
ARVD3
|
[NCBI]
|
0.000572675
|
|
|
CARASIL
|
[NCBI]
|
0.000572675
|
|
|
ARVD4
|
[NCBI]
|
0.000572675
|
|
|
CTPP1
|
[NCBI]
|
0.000525354
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
0.000525354
|
|
|
CTAA1
|
[NCBI]
|
0.000525354
|
|
|
ETM2
|
[NCBI]
|
0.000525354
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000525354
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000525354
|
|
|
CHED1
|
[NCBI]
|
0.00048785
|
|
|
inclusion body myositis
|
[NCBI]
|
0.000456834
|
|
|
SHFM2
|
[NCBI]
|
0.000456834
|
|
|
MYMY1
|
[NCBI]
|
0.000456834
|
|
|
robinow syndrome, autosomal dominant
|
[NCBI]
|
0.000430428
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000430428
|
|
|
TNF
|
[NCBI]
|
0.000408647
|
|
|
EEC3
|
[NCBI]
|
0.000405629
|
|
|
VEGF
|
[NCBI]
|
0.000388823
|
|
|
HPCX
|
[NCBI]
|
0.000387188
|
|
|
autism
|
[NCBI]
|
0.00037411
|
|
|
pygmy
|
[NCBI]
|
0.000369043
|
|
|
IBD5
|
[NCBI]
|
0.000369043
|
|
|
EGF
|
[NCBI]
|
0.000362919
|
|
|
SMEI
|
[NCBI]
|
0.000357954
|
|
|
scott syndrome
|
[NCBI]
|
0.000337704
|
|
|
CBBM
|
[NCBI]
|
0.000337704
|
|
|
SCA14
|
[NCBI]
|
0.000328248
|
|
|
MODY
|
[NCBI]
|
0.000301211
|
|
|
adult syndrome
|
[NCBI]
|
0.000301089
|
|
|
IGAD1
|
[NCBI]
|
0.000299591
|
|
|
GPS
|
[NCBI]
|
0.000288646
|
|
|
LMNA
|
[NCBI]
|
0.000282751
|
|
|
LMS
|
[NCBI]
|
0.000279351
|
|
|
SHFM3
|
[NCBI]
|
0.000278405
|
|
|
NGFB
|
[NCBI]
|
0.000270154
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000268791
|
|
|
NLS
|
[NCBI]
|
0.000268791
|
|
|
VUR1
|
[NCBI]
|
0.000259738
|
|
|
AD
|
[NCBI]
|
0.000252289
|
|
|
DFNB67
|
[NCBI]
|
0.000239036
|
|
|
CCD
|
[NCBI]
|
0.000234272
|
|
|
NS1
|
[NCBI]
|
0.000226862
|
|
|
myasthenic syndrome, congenital, fast-channel
|
[NCBI]
|
0.000224107
|
|
|
porphyria variegata
|
[NCBI]
|
0.000222962
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000221164
|
|
|
LGMD2I
|
[NCBI]
|
0.000219062
|
|
|
PRL
|
[NCBI]
|
0.000216856
|
|
|
CRC
|
[NCBI]
|
0.000215921
|
|
|
IBM3
|
[NCBI]
|
0.000209162
|
|
|
MDC1C
|
[NCBI]
|
0.000209162
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
0.000204368
|
|
|
GJB2
|
[NCBI]
|
0.000204359
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000192994
|
|
|
CACNA1A
|
[NCBI]
|
0.000192961
|
|
|
FHM2
|
[NCBI]
|
0.00019031
|
|
|
SPS
|
[NCBI]
|
0.000185379
|
|
|
giant platelet syndrome
|
[NCBI]
|
0.000185231
|
|
|
NPY
|
[NCBI]
|
0.000183233
|
|
|
APL
|
[NCBI]
|
0.00017359
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000172168
|
|
|
EVA
|
[NCBI]
|
0.000171355
|
|
|
PTH
|
[NCBI]
|
0.000169467
|
|
|
SCN5A
|
[NCBI]
|
0.000168831
|
|
|
DFNA6
|
[NCBI]
|
0.000168743
|
|
|
RHS
|
[NCBI]
|
0.000168743
|
|
|
EKV
|
[NCBI]
|
0.000164006
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
0.000163367
|
|
|
PPR
|
[NCBI]
|
0.000161444
|
|
|
PTPN11
|
[NCBI]
|
0.000161411
|
|
|
ARMD3
|
[NCBI]
|
0.000159343
|
|
|
carney complex variant
|
[NCBI]
|
0.000159343
|
|
|
NS5
|
[NCBI]
|
0.000159343
|
|
|
cardiomyopathy, dilated, with quadriceps myopathy
|
[NCBI]
|
0.000159343
|
|
|
epilepsy, myoclonic, x-linked, with mental retardation and spasticity
|
[NCBI]
|
0.000159343
|
|
|
PDS
|
[NCBI]
|
0.000158238
|
|
|
HFTC
|
[NCBI]
|
0.000154722
|
|
|
SHFM1
|
[NCBI]
|
0.000153003
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
0.00014863
|
|
|
MTS
|
[NCBI]
|
0.00014863
|
|
|
LGMD1C
|
[NCBI]
|
0.000144778
|
|
|
CPVT
|
[NCBI]
|
0.000144778
|
|
|
SQT1
|
[NCBI]
|
0.000144778
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
0.000144778
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
0.000144778
|
|
|
ND
|
[NCBI]
|
0.000136852
|
|
|
myopathy, myosin storage
|
[NCBI]
|
0.000134896
|
|
|
SANDO
|
[NCBI]
|
0.000134896
|
|
|
PGL4
|
[NCBI]
|
0.000134896
|
|
|
LADD
|
[NCBI]
|
0.000134896
|
|
|
FPLD2
|
[NCBI]
|
0.000133906
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
0.000133017
|
|
|
RTT
|
[NCBI]
|
0.000130832
|
|
|
GEFS+
|
[NCBI]
|
0.000128513
|
|
|
ATP1A2
|
[NCBI]
|
0.000128414
|
|
|
LGMD2A
|
[NCBI]
|
0.000127852
|
|
|
fabry disease
|
[NCBI]
|
0.00012781
|
|
|
SLOS
|
[NCBI]
|
0.000127494
|
|
|
TH
|
[NCBI]
|
0.00012678
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
0.000126537
|
|
|
SPG10
|
[NCBI]
|
0.000126537
|
|
|
USH2A
|
[NCBI]
|
0.000125427
|
|
|
MFS
|
[NCBI]
|
0.00012285
|
|
|
FHM3
|
[NCBI]
|
0.000121465
|
|
|
ALS8
|
[NCBI]
|
0.000121465
|
|
|
hypothyroidism, athyroidal, with spiky hair and cleft palate
|
[NCBI]
|
0.000121465
|
|
|
EDMD3
|
[NCBI]
|
0.000121465
|
|
|
preaxial deficiency, postaxial polydactyly, and hypospadias
|
[NCBI]
|
0.000121465
|
|
|
charcot-marie-tooth disease, axonal, type 2f
|
[NCBI]
|
0.000121465
|
|
|
HJMD
|
[NCBI]
|
0.000121465
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
0.000121465
|
|
|
MAPT
|
[NCBI]
|
0.000121403
|
|
|
KCNQ1
|
[NCBI]
|
0.000120424
|
|
|
CJD
|
[NCBI]
|
0.000120165
|
|
|
PRKCG
|
[NCBI]
|
0.000120058
|
|
|
sialuria
|
[NCBI]
|
0.000119302
|
|
|
HFE4
|
[NCBI]
|
0.000119302
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
0.000119302
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
0.000119302
|
|
|
keratitis-ichthyosis-deafness syndrome, autosomal dominant
|
[NCBI]
|
0.000119302
|
|
|
POLG
|
[NCBI]
|
0.000119235
|
|
|
VWS
|
[NCBI]
|
0.000118952
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
0.000116573
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
0.000112923
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
0.000109668
|
|
|
RMD
|
[NCBI]
|
0.000109668
|
|
|
FLNA
|
[NCBI]
|
0.000109171
|
|
|
SLC26A4
|
[NCBI]
|
0.000108388
|
|
|
EPO
|
[NCBI]
|
0.000108198
|
|
|
MECP2
|
[NCBI]
|
0.000107665
|
|
|
CMT4A
|
[NCBI]
|
0.00010725
|
|
|
SEDC
|
[NCBI]
|
0.000106475
|
|
|
central core disease of muscle
|
[NCBI]
|
0.000106475
|
|
|
ACHE
|
[NCBI]
|
0.000105696
|
|
|
SCN1A
|
[NCBI]
|
0.000105542
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
0.000105308
|
|
|
MLASA
|
[NCBI]
|
0.000104553
|
|
|
charcot-marie-tooth disease, axonal, with vocal cord paresis, autosomal recessive
|
[NCBI]
|
0.000104553
|
|
|
HHF3
|
[NCBI]
|
0.000104553
|
|
|
TS
|
[NCBI]
|
0.000104553
|
|
|
DFNB59
|
[NCBI]
|
0.000104553
|
|
|
martsolf syndrome
|
[NCBI]
|
0.000104553
|
|
|
SLC22A5
|
[NCBI]
|
0.000103848
|
|
|
RP
|
[NCBI]
|
0.000102941
|
|
|
NM
|
[NCBI]
|
0.000102126
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
0.000102126
|
|
|
CMT2A1
|
[NCBI]
|
0.000102126
|
|
|
papillorenal syndrome
|
[NCBI]
|
0.000102126
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
0.000102126
|
|
|
ALS2
|
[NCBI]
|
0.000102126
|
|
|
OPPG
|
[NCBI]
|
0.000102126
|
|
|
FHM1
|
[NCBI]
|
0.000100534
|
|
|
HGF
|
[NCBI]
|
0.000100325
|
|
|
TP73L
|
[NCBI]
|
9.9168e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
9.77629e-05
|
|
|
KCNJ11
|
[NCBI]
|
9.7726e-05
|
|
|
CAV3
|
[NCBI]
|
9.7726e-05
|
|
|
AFP
|
[NCBI]
|
9.77e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
9.74671e-05
|
|
|
PNDM
|
[NCBI]
|
9.74671e-05
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
9.74671e-05
|
|
|
BDNF
|
[NCBI]
|
9.70302e-05
|
|
|
MBP
|
[NCBI]
|
9.48223e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
9.31993e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
9.31993e-05
|
|
|
NEM1
|
[NCBI]
|
9.3062e-05
|
|
|
CTPP3
|
[NCBI]
|
9.3062e-05
|
|
|
HFE
|
[NCBI]
|
9.18441e-05
|
|
|
BCPM
|
[NCBI]
|
9.01317e-05
|
|
|
MYH7
|
[NCBI]
|
8.95408e-05
|
|
|
alexander disease
|
[NCBI]
|
8.92665e-05
|
|
|
PRKAG2
|
[NCBI]
|
8.91697e-05
|
|
|
WFS1
|
[NCBI]
|
8.90048e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
8.86856e-05
|
|
|
AIS
|
[NCBI]
|
8.86226e-05
|
|
|
JAG1
|
[NCBI]
|
8.78087e-05
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
8.77891e-05
|
|
|
FKRP
|
[NCBI]
|
8.58438e-05
|
|
|
EVR1
|
[NCBI]
|
8.56233e-05
|
|
|
CMD1E
|
[NCBI]
|
8.43446e-05
|
|
|
LGMD2F
|
[NCBI]
|
8.43446e-05
|
|
|
keratoderma, palmoplantar, with deafness
|
[NCBI]
|
8.43446e-05
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
8.43446e-05
|
|
|
HOA
|
[NCBI]
|
8.43446e-05
|
|
|
cataract, lamellar
|
[NCBI]
|
8.43446e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2j
|
[NCBI]
|
8.43446e-05
|
|
|
DFNA20
|
[NCBI]
|
8.43446e-05
|
|
|
LHFPL5
|
[NCBI]
|
8.4156e-05
|
|
|
SPG4
|
[NCBI]
|
8.33669e-05
|
|
|
BRAF
|
[NCBI]
|
8.27147e-05
|
|
|
GLA
|
[NCBI]
|
8.27147e-05
|
|
|
leopard syndrome 1
|
[NCBI]
|
8.22331e-05
|
|
|
SDHB
|
[NCBI]
|
8.17401e-05
|
|
|
MM
|
[NCBI]
|
8.12763e-05
|
|
|
FGFR3
|
[NCBI]
|
8.03209e-05
|
|
|
PRSS1
|
[NCBI]
|
8.03059e-05
|
|
|
immotile cilia syndrome due to excessively long cilia
|
[NCBI]
|
7.96642e-05
|
|
|
ASD4
|
[NCBI]
|
7.96642e-05
|
|
|
ichthyosis, hystrix-like, with deafness
|
[NCBI]
|
7.96642e-05
|
|
|
HMN2B
|
[NCBI]
|
7.96642e-05
|
|
|
leopard syndrome 2
|
[NCBI]
|
7.96642e-05
|
|
|
COFS2
|
[NCBI]
|
7.96642e-05
|
|
|
hypodontia, x-linked
|
[NCBI]
|
7.96642e-05
|
|
|
ARB
|
[NCBI]
|
7.96642e-05
|
|
|
CORD10
|
[NCBI]
|
7.96642e-05
|
|
|
CMD1M
|
[NCBI]
|
7.96642e-05
|
|
|
arthropathy, tendinous calcinosis, and progeroid features
|
[NCBI]
|
7.96642e-05
|
|
|
ATFB4
|
[NCBI]
|
7.96642e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 4
|
[NCBI]
|
7.96642e-05
|
|
|
furlong syndrome: fs
|
[NCBI]
|
7.96642e-05
|
|
|
CMD1I
|
[NCBI]
|
7.96642e-05
|
|
|
CMD1N
|
[NCBI]
|
7.96642e-05
|
|
|
hepatic adenomas, familial
|
[NCBI]
|
7.96642e-05
|
|
|
NPHS3
|
[NCBI]
|
7.96642e-05
|
|
|
van buchem disease, type 2
|
[NCBI]
|
7.96642e-05
|
|
|
RDC
|
[NCBI]
|
7.96642e-05
|
|
|
CSNB2B
|
[NCBI]
|
7.96642e-05
|
|
|
CDG2B
|
[NCBI]
|
7.96642e-05
|
|
|
DMGDHD
|
[NCBI]
|
7.96642e-05
|
|
|
skin fragility-woolly hair syndrome
|
[NCBI]
|
7.96642e-05
|
|
|
diarrhea 4, malabsorptive, congenital
|
[NCBI]
|
7.96642e-05
|
|
|
MCOPCB5
|
[NCBI]
|
7.96642e-05
|
|
|
ADCAD2
|
[NCBI]
|
7.96642e-05
|
|
|
retinitis pigmentosa 37
|
[NCBI]
|
7.96642e-05
|
|
|
charcot-marie-tooth disease, demyelinating, type 1f
|
[NCBI]
|
7.96642e-05
|
|
|
caroli disease, isolated
|
[NCBI]
|
7.96642e-05
|
|
|
thyroid hormone metabolism, abnormal
|
[NCBI]
|
7.96642e-05
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
7.96642e-05
|
|
|
hypotrichosis-lymphedema-telangiectasia syndrome
|
[NCBI]
|
7.96642e-05
|
|
|
DFNB23
|
[NCBI]
|
7.96642e-05
|
|
|
phosphoserine aminotransferase deficiency
|
[NCBI]
|
7.96642e-05
|
|
|
ectopia pupillae
|
[NCBI]
|
7.96642e-05
|
|
|
NEM4
|
[NCBI]
|
7.96642e-05
|
|
|
RP35
|
[NCBI]
|
7.96642e-05
|
|
|
ectrodactyly-cleft palate syndrome
|
[NCBI]
|
7.96642e-05
|
|
|
ATFB3
|
[NCBI]
|
7.96642e-05
|
|
|
ELAC2
|
[NCBI]
|
7.96447e-05
|
|
|
TMPRSS3
|
[NCBI]
|
7.94368e-05
|
|
|
IBM2
|
[NCBI]
|
7.90661e-05
|
|
|
ESCS
|
[NCBI]
|
7.90661e-05
|
|
|
PRF1
|
[NCBI]
|
7.73997e-05
|
|
|
CCA2
|
[NCBI]
|
7.73347e-05
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
7.73347e-05
|
|
|
PC1
|
[NCBI]
|
7.73347e-05
|
|
|
HNSCC
|
[NCBI]
|
7.73347e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
7.73347e-05
|
|
|
CZP3
|
[NCBI]
|
7.73347e-05
|
|
|
FHL2
|
[NCBI]
|
7.73347e-05
|
|
|
ORW2
|
[NCBI]
|
7.6097e-05
|
|
|
TBCE
|
[NCBI]
|
7.56977e-05
|
|
|
PPOX
|
[NCBI]
|
7.34389e-05
|
|
|
SPG4
|
[NCBI]
|
7.34389e-05
|
|
|
EDMD2
|
[NCBI]
|
7.3305e-05
|
|
|
DHCR7
|
[NCBI]
|
7.25539e-05
|
|
|
PXE
|
[NCBI]
|
7.24113e-05
|
|
|
NPPA
|
[NCBI]
|
7.18327e-05
|
|
|
CDG1B
|
[NCBI]
|
7.1487e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
7.1487e-05
|
|
|
ODG2
|
[NCBI]
|
7.1487e-05
|
|
|
IBMPFD
|
[NCBI]
|
7.1487e-05
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
7.1487e-05
|
|
|
FBN1
|
[NCBI]
|
7.03898e-05
|
|
|
CDSP
|
[NCBI]
|
7.01459e-05
|
|
|
KCNH2
|
[NCBI]
|
6.9678e-05
|
|
|
DKC1
|
[NCBI]
|
6.95902e-05
|
|
|
ZS
|
[NCBI]
|
6.93303e-05
|
|
|
USH2A
|
[NCBI]
|
6.81834e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
6.81834e-05
|
|
|
DES
|
[NCBI]
|
6.77822e-05
|
|
|
KRT17
|
[NCBI]
|
6.71987e-05
|
|
|
DNM2
|
[NCBI]
|
6.71987e-05
|
|
|
VMD
|
[NCBI]
|
6.68919e-05
|
|
|
DFNA3
|
[NCBI]
|
6.64831e-05
|
|
|
HFE3
|
[NCBI]
|
6.64831e-05
|
|
|
gitelman syndrome
|
[NCBI]
|
6.64831e-05
|
|
|
SBS
|
[NCBI]
|
6.64831e-05
|
|
|
HHF6
|
[NCBI]
|
6.64831e-05
|
|
|
BRCA1
|
[NCBI]
|
6.62351e-05
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
6.58254e-05
|
|
|
LRP5
|
[NCBI]
|
6.56701e-05
|
|
|
EGR2
|
[NCBI]
|
6.56701e-05
|
|
|
MPZ
|
[NCBI]
|
6.53444e-05
|
|
|
FMF
|
[NCBI]
|
6.49368e-05
|
|
|
ENG
|
[NCBI]
|
6.45044e-05
|
|
|
BCNS
|
[NCBI]
|
6.36338e-05
|
|
|
MHA
|
[NCBI]
|
6.35868e-05
|
|
|
L1CAM
|
[NCBI]
|
6.22536e-05
|
|
|
CTSC
|
[NCBI]
|
6.22536e-05
|
|
|
GJA8
|
[NCBI]
|
6.22444e-05
|
|
|
PSACH
|
[NCBI]
|
6.21815e-05
|
|
|
MC4R
|
[NCBI]
|
6.21625e-05
|
|
|
NETH
|
[NCBI]
|
6.21205e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
6.21205e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
6.21205e-05
|
|
|
muenke syndrome
|
[NCBI]
|
6.21205e-05
|
|
|
ARX
|
[NCBI]
|
6.11929e-05
|
|
|
KRT14
|
[NCBI]
|
6.11929e-05
|
|
|
EPM2A
|
[NCBI]
|
6.10494e-05
|
|
|
FGF23
|
[NCBI]
|
6.08392e-05
|
|
|
PAX6
|
[NCBI]
|
6.05859e-05
|
|
|
RYR2
|
[NCBI]
|
6.0181e-05
|
|
|
RHO
|
[NCBI]
|
5.97858e-05
|
|
|
KIF5A
|
[NCBI]
|
5.95736e-05
|
|
|
KCNE2
|
[NCBI]
|
5.95736e-05
|
|
|
CHST6
|
[NCBI]
|
5.95736e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
5.95566e-05
|
|
|
VHL
|
[NCBI]
|
5.90171e-05
|
|
|
LGMD1A
|
[NCBI]
|
5.82619e-05
|
|
|
scheie syndrome
|
[NCBI]
|
5.82619e-05
|
|
|
CMT2A2
|
[NCBI]
|
5.82619e-05
|
|
|
AVP
|
[NCBI]
|
5.7967e-05
|
|
|
IRF6
|
[NCBI]
|
5.77273e-05
|
|
|
BEST1
|
[NCBI]
|
5.77273e-05
|
|
|
MTND5
|
[NCBI]
|
5.73572e-05
|
|
|
FBLN5
|
[NCBI]
|
5.59297e-05
|
|
|
KCNE3
|
[NCBI]
|
5.59297e-05
|
|
|
NHLRC1
|
[NCBI]
|
5.59297e-05
|
|
|
ATP2C1
|
[NCBI]
|
5.59297e-05
|
|
|
PTEN
|
[NCBI]
|
5.53756e-05
|
|
|
VHL
|
[NCBI]
|
5.53615e-05
|
|
|
ACTA1
|
[NCBI]
|
5.48399e-05
|
|
|
MRXS13
|
[NCBI]
|
5.48102e-05
|
|
|
SACS
|
[NCBI]
|
5.48102e-05
|
|
|
HHS
|
[NCBI]
|
5.48102e-05
|
|
|
LIS1
|
[NCBI]
|
5.48102e-05
|
|
|
MPO
|
[NCBI]
|
5.41598e-05
|
|
|
ABCC6
|
[NCBI]
|
5.40083e-05
|
|
|
GBA
|
[NCBI]
|
5.3648e-05
|
|
|
DHFR
|
[NCBI]
|
5.30021e-05
|
|
|
SLC39A4
|
[NCBI]
|
5.29362e-05
|
|
|
NEU1
|
[NCBI]
|
5.22889e-05
|
|
|
WFS2
|
[NCBI]
|
5.22695e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
5.22695e-05
|
|
|
pyridoxamine 5-prime-phosphate oxidase deficiency
|
[NCBI]
|
5.22695e-05
|
|
|
bruck syndrome 2
|
[NCBI]
|
5.22695e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
5.22695e-05
|
|
|
MCOP3
|
[NCBI]
|
5.22695e-05
|
|
|
cahmr syndrome
|
[NCBI]
|
5.22695e-05
|
|
|
diabetes mellitus, transient neonatal, 2
|
[NCBI]
|
5.22695e-05
|
|
|
glycine n-methyltransferase deficiency
|
[NCBI]
|
5.22695e-05
|
|
|
ectrodactyly and ectodermal dysplasia without cleft lip/palate
|
[NCBI]
|
5.22695e-05
|
|
|
hyperthyroidism, familial gestational
|
[NCBI]
|
5.22695e-05
|
|
|
BOR2
|
[NCBI]
|
5.22695e-05
|
|
|
SQT3
|
[NCBI]
|
5.22695e-05
|
|
|
ASD2
|
[NCBI]
|
5.22695e-05
|
|
|
pilomatrixoma
|
[NCBI]
|
5.22695e-05
|
|
|
scapuloperoneal myopathy, x-linked dominant
|
[NCBI]
|
5.22695e-05
|
|
|
hypoplastic left heart syndrome
|
[NCBI]
|
5.22695e-05
|
|
|
cardiomyopathy, infantile histiocytoid
|
[NCBI]
|
5.22695e-05
|
|
|
VUR2
|
[NCBI]
|
5.22695e-05
|
|
|
amyloidosis, cerebroarterial, hereditary, iowa type
|
[NCBI]
|
5.22695e-05
|
|
|
glycogen storage disease of heart, lethal congenital
|
[NCBI]
|
5.22695e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
5.22695e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
5.22695e-05
|
|
|
autism, x-linked, susceptibility to, 3
|
[NCBI]
|
5.22695e-05
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
5.22695e-05
|
|
|
GS3
|
[NCBI]
|
5.22695e-05
|
|
|
dystonia, juvenile-onset
|
[NCBI]
|
5.22695e-05
|
|
|
SQT2
|
[NCBI]
|
5.22695e-05
|
|
|
LIS3
|
[NCBI]
|
5.22695e-05
|
|
|
TCC
|
[NCBI]
|
5.22695e-05
|
|
|
diabetes mellitus, transient neonatal, 3
|
[NCBI]
|
5.22695e-05
|
|
|
CDG1H
|
[NCBI]
|
5.22695e-05
|
|
|
PPCD2
|
[NCBI]
|
5.22695e-05
|
|
|
cholestasis, benign recurrent intrahepatic 2
|
[NCBI]
|
5.22695e-05
|
|
|
SCRA
|
[NCBI]
|
5.22695e-05
|
|
|
SCDO3
|
[NCBI]
|
5.22695e-05
|
|
|
c-like syndrome
|
[NCBI]
|
5.22695e-05
|
|
|
CCA3
|
[NCBI]
|
5.22695e-05
|
|
|
XMPMA
|
[NCBI]
|
5.22695e-05
|
|
|
ichthyosis, cyclic, with epidermolytic hyperkeratosis
|
[NCBI]
|
5.22695e-05
|
|
|
CMT1D
|
[NCBI]
|
5.22695e-05
|
|
|
bothnia retinal dystrophy
|
[NCBI]
|
5.22695e-05
|
|
|
DSMA4
|
[NCBI]
|
5.22695e-05
|
|
|
optic atrophy 3, autosomal dominant
|
[NCBI]
|
5.22695e-05
|
|
|
heterotopia, periventricular, ehlers-danlos variant
|
[NCBI]
|
5.22695e-05
|
|
|
HMN7B
|
[NCBI]
|
5.22695e-05
|
|
|
spondyloepimetaphyseal dysplasia, type ii
|
[NCBI]
|
5.22695e-05
|
|
|
knuckle pads, leukonychia, and sensorineural deafness
|
[NCBI]
|
5.22695e-05
|
|
|
neutropenia, nonimmune chronic idiopathic, of adults
|
[NCBI]
|
5.22695e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2l
|
[NCBI]
|
5.22695e-05
|
|
|
OPD1
|
[NCBI]
|
5.16938e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
5.16938e-05
|
|
|
DSMA1
|
[NCBI]
|
5.16938e-05
|
|
|
LDS
|
[NCBI]
|
5.16938e-05
|
|
|
pick disease of brain
|
[NCBI]
|
5.16938e-05
|
|
|
monilethrix
|
[NCBI]
|
5.16938e-05
|
|
|
FTNS
|
[NCBI]
|
5.16938e-05
|
|
|
BMND1
|
[NCBI]
|
5.16938e-05
|
|
|
AEZ
|
[NCBI]
|
5.16938e-05
|
|
|
ED2
|
[NCBI]
|
5.16938e-05
|
|
|
GJB6
|
[NCBI]
|
5.11174e-05
|
|
|
ATP7B
|
[NCBI]
|
5.10414e-05
|
|
|
cystinuria
|
[NCBI]
|
5.05508e-05
|
|
|
CASQ2
|
[NCBI]
|
5.03951e-05
|
|
|
costello syndrome
|
[NCBI]
|
4.8989e-05
|
|
|
SDHD
|
[NCBI]
|
4.89493e-05
|
|
|
APTX
|
[NCBI]
|
4.89493e-05
|
|
|
JAK2
|
[NCBI]
|
4.89168e-05
|
|
|
EA1
|
[NCBI]
|
4.88586e-05
|
|
|
NFNS
|
[NCBI]
|
4.88586e-05
|
|
|
coenzyme q10 deficiency
|
[NCBI]
|
4.88586e-05
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
4.88586e-05
|
|
|
tetralogy of fallot
|
[NCBI]
|
4.88586e-05
|
|
|
HMN5
|
[NCBI]
|
4.88586e-05
|
|
|
LGMD1B
|
[NCBI]
|
4.88586e-05
|
|
|
TRPS1
|
[NCBI]
|
4.81877e-05
|
|
|
FZD4
|
[NCBI]
|
4.81877e-05
|
|
|
SETX
|
[NCBI]
|
4.81877e-05
|
|
|
CNGB3
|
[NCBI]
|
4.81877e-05
|
|
|
TGFBI
|
[NCBI]
|
4.79422e-05
|
|
|
PMM2
|
[NCBI]
|
4.79422e-05
|
|
|
CRYAA
|
[NCBI]
|
4.79422e-05
|
|
|
GFAP
|
[NCBI]
|
4.75699e-05
|
|
|
CMD1A
|
[NCBI]
|
4.7488e-05
|
|
|
myoclonic dystonia
|
[NCBI]
|
4.7488e-05
|
|
|
PD
|
[NCBI]
|
4.73443e-05
|
|
|
MAFD6
|
[NCBI]
|
4.70385e-05
|
|
|
NKX2E
|
[NCBI]
|
4.69804e-05
|
|
|
ABCA1
|
[NCBI]
|
4.65568e-05
|
|
|
MLH1
|
[NCBI]
|
4.63376e-05
|
|
|
ADLTE
|
[NCBI]
|
4.62626e-05
|
|
|
PALS
|
[NCBI]
|
4.62626e-05
|
|
|
CFTD
|
[NCBI]
|
4.62626e-05
|
|
|
JH
|
[NCBI]
|
4.62626e-05
|
|
|
PPCD1
|
[NCBI]
|
4.62626e-05
|
|
|
danon disease
|
[NCBI]
|
4.62626e-05
|
|
|
LGMD2B
|
[NCBI]
|
4.62626e-05
|
|
|
SOST
|
[NCBI]
|
4.62626e-05
|
|
|
KRT16
|
[NCBI]
|
4.62373e-05
|
|
|
PEX1
|
[NCBI]
|
4.62373e-05
|
|
|
HOXA13
|
[NCBI]
|
4.62373e-05
|
|
|
MTM1
|
[NCBI]
|
4.60602e-05
|
|
|
FCAS
|
[NCBI]
|
4.60441e-05
|
|
|
CDPX2
|
[NCBI]
|
4.60441e-05
|
|
|
PCTT
|
[NCBI]
|
4.60441e-05
|
|
|
FIH
|
[NCBI]
|
4.46538e-05
|
|
|
SLC7A9
|
[NCBI]
|
4.44908e-05
|
|
|
KCNQ4
|
[NCBI]
|
4.44908e-05
|
|
|
TNNT2
|
[NCBI]
|
4.43321e-05
|
|
|
TTP
|
[NCBI]
|
4.38727e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
4.38727e-05
|
|
|
PARK6
|
[NCBI]
|
4.38727e-05
|
|
|
GCE
|
[NCBI]
|
4.38727e-05
|
|
|
NBIA1
|
[NCBI]
|
4.38727e-05
|
|
|
SLC25A4
|
[NCBI]
|
4.35186e-05
|
|
|
CDG1A
|
[NCBI]
|
4.33142e-05
|
|
|
MATN3
|
[NCBI]
|
4.29104e-05
|
|
|
ALPS2A
|
[NCBI]
|
4.21656e-05
|
|
|
DTGA1
|
[NCBI]
|
4.21656e-05
|
|
|
FECD1
|
[NCBI]
|
4.21656e-05
|
|
|
fibular hypoplasia and complex brachydactyly
|
[NCBI]
|
4.21656e-05
|
|
|
FEB8
|
[NCBI]
|
4.21656e-05
|
|
|
cataract, microcephaly, failure to thrive, kyphoscoliosis syndrome
|
[NCBI]
|
4.21656e-05
|
|
|
IAHSP
|
[NCBI]
|
4.21656e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
4.21656e-05
|
|
|
BDD
|
[NCBI]
|
4.21656e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
4.21656e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2i
|
[NCBI]
|
4.21656e-05
|
|
|
EDM5
|
[NCBI]
|
4.21656e-05
|
|
|
ARTS
|
[NCBI]
|
4.21656e-05
|
|
|
bile acid synthesis defect, congenital, 2
|
[NCBI]
|
4.21656e-05
|
|
|
chondrosarcoma
|
[NCBI]
|
4.21656e-05
|
|
|
insulin-like growth factor i, resistance to
|
[NCBI]
|
4.21656e-05
|
|
|
phosphoglycerate dehydrogenase deficiency
|
[NCBI]
|
4.21656e-05
|
|
|
coats disease
|
[NCBI]
|
4.21656e-05
|
|
|
bernard-soulier syndrome, benign autosomal dominant
|
[NCBI]
|
4.21656e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
4.21656e-05
|
|
|
MRX63
|
[NCBI]
|
4.21656e-05
|
|
|
CMTX5
|
[NCBI]
|
4.21656e-05
|
|
|
CVT
|
[NCBI]
|
4.21656e-05
|
|
|
NSIAD
|
[NCBI]
|
4.21656e-05
|
|
|
xeroderma pigmentosum ix
|
[NCBI]
|
4.21656e-05
|
|
|
OGD
|
[NCBI]
|
4.21656e-05
|
|
|
CLN10
|
[NCBI]
|
4.21656e-05
|
|
|
gonadal dysgenesis, 46,xy, partial, with minifascicular neuropathy
|
[NCBI]
|
4.21656e-05
|
|
|
FEB3
|
[NCBI]
|
4.21656e-05
|
|
|
LDHCP
|
[NCBI]
|
4.21656e-05
|
|
|
SERKAL
|
[NCBI]
|
4.21656e-05
|
|
|
MADB
|
[NCBI]
|
4.21656e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
4.21656e-05
|
|
|
aminoacylase 1 deficiency
|
[NCBI]
|
4.21656e-05
|
|
|
ADCAD1
|
[NCBI]
|
4.21656e-05
|
|
|
DFNA36
|
[NCBI]
|
4.21656e-05
|
|
|
camptodactyly, tall stature, and hearing loss syndrome
|
[NCBI]
|
4.21656e-05
|
|
|
CMD1P
|
[NCBI]
|
4.21656e-05
|
|
|
JPHT
|
[NCBI]
|
4.21656e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
4.21656e-05
|
|
|
neuropathy, hereditary sensory, with spastic paraplegia, autosomal recessive
|
[NCBI]
|
4.21656e-05
|
|
|
osteoarthritis with mild chondrodysplasia
|
[NCBI]
|
4.21656e-05
|
|
|
ACVRL1
|
[NCBI]
|
4.19811e-05
|
|
|
PRODH
|
[NCBI]
|
4.19811e-05
|
|
|
FGFR2
|
[NCBI]
|
4.19036e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
4.1662e-05
|
|
|
blood group, p system
|
[NCBI]
|
4.1662e-05
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
4.1662e-05
|
|
|
SCCMS
|
[NCBI]
|
4.1662e-05
|
|
|
GACI
|
[NCBI]
|
4.1662e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
4.1534e-05
|
|
|
CD
|
[NCBI]
|
4.15029e-05
|
|
|
MCOLN1
|
[NCBI]
|
4.14679e-05
|
|
|
ALPL
|
[NCBI]
|
4.12531e-05
|
|
|
MEFV
|
[NCBI]
|
4.12531e-05
|
|
|
BTHS
|
[NCBI]
|
4.07757e-05
|
|
|
KRT5
|
[NCBI]
|
4.055e-05
|
|
|
TECTA
|
[NCBI]
|
4.01416e-05
|
|
|
PAFAH1B1
|
[NCBI]
|
3.98703e-05
|
|
|
pejvakin
|
[NCBI]
|
3.97131e-05
|
|
|
EFHC1
|
[NCBI]
|
3.97131e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
3.96088e-05
|
|
|
EAOH
|
[NCBI]
|
3.96088e-05
|
|
|
FBS
|
[NCBI]
|
3.96088e-05
|
|
|
FMO3
|
[NCBI]
|
3.92125e-05
|
|
|
GDAP1
|
[NCBI]
|
3.89148e-05
|
|
|
KCNQ2
|
[NCBI]
|
3.89148e-05
|
|
|
GGCX
|
[NCBI]
|
3.89148e-05
|
|
|
SPG3A
|
[NCBI]
|
3.89148e-05
|
|
|
PKHD1
|
[NCBI]
|
3.89148e-05
|
|
|
HSCR1
|
[NCBI]
|
3.85386e-05
|
|
|
NPHS1
|
[NCBI]
|
3.7774e-05
|
|
|
RAPSN
|
[NCBI]
|
3.7774e-05
|
|
|
EBN1
|
[NCBI]
|
3.7695e-05
|
|
|
BFLS
|
[NCBI]
|
3.7695e-05
|
|
|
brugada syndrome 1
|
[NCBI]
|
3.7695e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.73077e-05
|
|
|
CHAT
|
[NCBI]
|
3.69203e-05
|
|
|
RS1
|
[NCBI]
|
3.67768e-05
|
|
|
FOXE3
|
[NCBI]
|
3.62418e-05
|
|
|
COQ2
|
[NCBI]
|
3.62418e-05
|
|
|
GPR56
|
[NCBI]
|
3.62418e-05
|
|
|
PUS1
|
[NCBI]
|
3.62418e-05
|
|
|
NOD2
|
[NCBI]
|
3.62116e-05
|
|
|
JPS
|
[NCBI]
|
3.61963e-05
|
|
|
canavan disease
|
[NCBI]
|
3.59055e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
3.59055e-05
|
|
|
IGAD2
|
[NCBI]
|
3.5737e-05
|
|
|
HAE III
|
[NCBI]
|
3.5737e-05
|
|
|
sick sinus syndrome, autosomal dominant
|
[NCBI]
|
3.5737e-05
|
|
|
PRTS
|
[NCBI]
|
3.5737e-05
|
|
|
BJS
|
[NCBI]
|
3.5737e-05
|
|
|
OPTA1
|
[NCBI]
|
3.5737e-05
|
|
|
CDG1D
|
[NCBI]
|
3.5737e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
3.5737e-05
|
|
|
CSNBAD1
|
[NCBI]
|
3.5737e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
3.5737e-05
|
|
|
tietz syndrome
|
[NCBI]
|
3.5737e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
3.5737e-05
|
|
|
CMM3
|
[NCBI]
|
3.5737e-05
|
|
|
SCA13
|
[NCBI]
|
3.5737e-05
|
|
|
isobutyryl-coa dehydrogenase deficiency
|
[NCBI]
|
3.5737e-05
|
|
|
FSGS2
|
[NCBI]
|
3.5737e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
3.5737e-05
|
|
|
rett syndrome, atypical, cdkl5-related
|
[NCBI]
|
3.5737e-05
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
3.5737e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
3.5737e-05
|
|
|
fibromatosis, juvenile hyaline
|
[NCBI]
|
3.5737e-05
|
|
|
LGMD2K
|
[NCBI]
|
3.5737e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
3.5737e-05
|
|
|
CDG1K
|
[NCBI]
|
3.5737e-05
|
|
|
LI3
|
[NCBI]
|
3.5737e-05
|
|
|
PURE&apos
|
[NCBI]
|
3.5737e-05
|
|
|
CMT1C
|
[NCBI]
|
3.5737e-05
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
3.5737e-05
|
|
|
cervical cancer
|
[NCBI]
|
3.5737e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
3.5737e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
3.5737e-05
|
|
|
SPG7
|
[NCBI]
|
3.5737e-05
|
|
|
ADSL
|
[NCBI]
|
3.57089e-05
|
|
|
ITGB4
|
[NCBI]
|
3.57089e-05
|
|
|
GJA3
|
[NCBI]
|
3.57089e-05
|
|
|
GLRA1
|
[NCBI]
|
3.57089e-05
|
|
|
MYOC
|
[NCBI]
|
3.53588e-05
|
|
|
TSC2
|
[NCBI]
|
3.50867e-05
|
|
|
PTK2
|
[NCBI]
|
3.50309e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
3.47682e-05
|
|
|
FOXL2
|
[NCBI]
|
3.47682e-05
|
|
|
FLT4
|
[NCBI]
|
3.47682e-05
|
|
|
GLC3A
|
[NCBI]
|
3.42274e-05
|
|
|
MNGIE
|
[NCBI]
|
3.42274e-05
|
|
|
MTCYB
|
[NCBI]
|
3.41001e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
3.38802e-05
|
|
|
CYP17A1
|
[NCBI]
|
3.36061e-05
|
|
|
MYH8
|
[NCBI]
|
3.35941e-05
|
|
|
ABCB7
|
[NCBI]
|
3.35941e-05
|
|
|
GJB4
|
[NCBI]
|
3.35941e-05
|
|
|
IMPA2
|
[NCBI]
|
3.35941e-05
|
|
|
HAMP
|
[NCBI]
|
3.30394e-05
|
|
|
HR
|
[NCBI]
|
3.30394e-05
|
|
|
SLC2A1
|
[NCBI]
|
3.30394e-05
|
|
|
SMA1
|
[NCBI]
|
3.27551e-05
|
|
|
AHO
|
[NCBI]
|
3.27551e-05
|
|
|
APOE
|
[NCBI]
|
3.27221e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
3.26498e-05
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
3.26498e-05
|
|
|
ADAMTS13
|
[NCBI]
|
3.22414e-05
|
|
|
NF1
|
[NCBI]
|
3.15691e-05
|
|
|
PSEN1
|
[NCBI]
|
3.14882e-05
|
|
|
GJB3
|
[NCBI]
|
3.14822e-05
|
|
|
TPM2
|
[NCBI]
|
3.14535e-05
|
|
|
SLURP1
|
[NCBI]
|
3.14535e-05
|
|
|
TTID
|
[NCBI]
|
3.14535e-05
|
|
|
MYH2
|
[NCBI]
|
3.14535e-05
|
|
|
CRYM
|
[NCBI]
|
3.14535e-05
|
|
|
WAS
|
[NCBI]
|
3.13106e-05
|
|
|
BRRS
|
[NCBI]
|
3.12505e-05
|
|
|
MLC
|
[NCBI]
|
3.11634e-05
|
|
|
MADA
|
[NCBI]
|
3.11634e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
3.11634e-05
|
|
|
SHBG
|
[NCBI]
|
3.11429e-05
|
|
|
CFTR
|
[NCBI]
|
3.10989e-05
|
|
|
neurofibromatosis, familial spinal
|
[NCBI]
|
3.1054e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
3.1054e-05
|
|
|
CCZS
|
[NCBI]
|
3.1054e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type ii
|
[NCBI]
|
3.1054e-05
|
|
|
formiminotransferase deficiency
|
[NCBI]
|
3.1054e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
3.1054e-05
|
|
|
JAE
|
[NCBI]
|
3.1054e-05
|
|
|
pseudohypoaldosteronism, type i, autosomal dominant
|
[NCBI]
|
3.1054e-05
|
|
|
EDM2
|
[NCBI]
|
3.1054e-05
|
|
|
gout, hprt-related
|
[NCBI]
|
3.1054e-05
|
|
|
ALSG
|
[NCBI]
|
3.1054e-05
|
|
|
NAIC
|
[NCBI]
|
3.1054e-05
|
|
|
orthostatic intolerance
|
[NCBI]
|
3.1054e-05
|
|
|
DFNA10
|
[NCBI]
|
3.1054e-05
|
|
|
MRX54
|
[NCBI]
|
3.1054e-05
|
|
|
DFNA13
|
[NCBI]
|
3.1054e-05
|
|
|
KRS
|
[NCBI]
|
3.1054e-05
|
|
|
LISX2
|
[NCBI]
|
3.1054e-05
|
|
|
osteolysis, hereditary multicentric
|
[NCBI]
|
3.1054e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
3.1054e-05
|
|
|
LI2
|
[NCBI]
|
3.1054e-05
|
|
|
watson syndrome
|
[NCBI]
|
3.1054e-05
|
|
|
EDM3
|
[NCBI]
|
3.1054e-05
|
|
|
GDD
|
[NCBI]
|
3.1054e-05
|
|
|
APBD
|
[NCBI]
|
3.1054e-05
|
|
|
CMD1D
|
[NCBI]
|
3.1054e-05
|
|
|
hyperostosis corticalis generalisata, benign form of worth, with torus palatinus
|
[NCBI]
|
3.1054e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
3.1054e-05
|
|
|
VF
|
[NCBI]
|
3.1054e-05
|
|
|
PC2
|
[NCBI]
|
3.1054e-05
|
|
|
AH
|
[NCBI]
|
3.1054e-05
|
|
|
epidermolysis bullosa herpetiformis, dowling-meara type
|
[NCBI]
|
3.1054e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
3.1054e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
3.1054e-05
|
|
|
LCA2
|
[NCBI]
|
3.1054e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
3.1054e-05
|
|
|
d-2-@hydroxyglutaric aciduria
|
[NCBI]
|
3.1054e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
3.08831e-05
|
|
|
UROS
|
[NCBI]
|
3.07585e-05
|
|
|
HNF1B
|
[NCBI]
|
3.07585e-05
|
|
|
MSX1
|
[NCBI]
|
3.07585e-05
|
|
|
F3
|
[NCBI]
|
3.05683e-05
|
|
|
obesity
|
[NCBI]
|
3.03501e-05
|
|
|
MIP
|
[NCBI]
|
3.00673e-05
|
|
|
SRD5A2
|
[NCBI]
|
3.00673e-05
|
|
|
LS
|
[NCBI]
|
2.99939e-05
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
2.97601e-05
|
|
|
SCDO1
|
[NCBI]
|
2.97601e-05
|
|
|
HOKPP
|
[NCBI]
|
2.97601e-05
|
|
|
TMC1
|
[NCBI]
|
2.9658e-05
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
2.9658e-05
|
|
|
KIF1B
|
[NCBI]
|
2.9658e-05
|
|
|
PAX2
|
[NCBI]
|
2.94059e-05
|
|
|
EXT1
|
[NCBI]
|
2.94059e-05
|
|
|
BMP15
|
[NCBI]
|
2.94059e-05
|
|
|
RET
|
[NCBI]
|
2.91983e-05
|
|
|
MSH2
|
[NCBI]
|
2.88813e-05
|
|
|
OPA1
|
[NCBI]
|
2.87721e-05
|
|
|
CFNS
|
[NCBI]
|
2.84328e-05
|
|
|
PBD
|
[NCBI]
|
2.84328e-05
|
|
|
MRXHF1
|
[NCBI]
|
2.84328e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
2.84328e-05
|
|
|
charge syndrome
|
[NCBI]
|
2.84328e-05
|
|
|
ODDD
|
[NCBI]
|
2.84328e-05
|
|
|
NEM3
|
[NCBI]
|
2.84328e-05
|
|
|
OCRL
|
[NCBI]
|
2.84328e-05
|
|
|
KRT12
|
[NCBI]
|
2.81131e-05
|
|
|
SACS
|
[NCBI]
|
2.81131e-05
|
|
|
NEUROG3
|
[NCBI]
|
2.81131e-05
|
|
|
CASP10
|
[NCBI]
|
2.81131e-05
|
|
|
MKKS
|
[NCBI]
|
2.81131e-05
|
|
|
CLCNKB
|
[NCBI]
|
2.81131e-05
|
|
|
hemojuvelin
|
[NCBI]
|
2.81131e-05
|
|
|
GRHPR
|
[NCBI]
|
2.81131e-05
|
|
|
CHRND
|
[NCBI]
|
2.81131e-05
|
|
|
FHL1
|
[NCBI]
|
2.81131e-05
|
|
|
BSCL2
|
[NCBI]
|
2.81131e-05
|
|
|
CYP4F22
|
[NCBI]
|
2.80493e-05
|
|
|
LHFPL4
|
[NCBI]
|
2.80493e-05
|
|
|
CISD2
|
[NCBI]
|
2.80493e-05
|
|
|
otospiralin
|
[NCBI]
|
2.80493e-05
|
|
|
VKORC1L1
|
[NCBI]
|
2.80493e-05
|
|
|
MTMR14
|
[NCBI]
|
2.80493e-05
|
|
|
homocystinuria
|
[NCBI]
|
2.80175e-05
|
|
|
IPF1
|
[NCBI]
|
2.75792e-05
|
|
|
STHAG1
|
[NCBI]
|
2.73991e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
2.73991e-05
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
2.73991e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
2.73991e-05
|
|
|
amyloidosis vii
|
[NCBI]
|
2.73991e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
2.73991e-05
|
|
|
HPE4
|
[NCBI]
|
2.73991e-05
|
|
|
gaucher disease, atypical, due to saposin c deficiency
|
[NCBI]
|
2.73991e-05
|
|
|
DFNB10
|
[NCBI]
|
2.73991e-05
|
|
|
OCA4
|
[NCBI]
|
2.73991e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2b1
|
[NCBI]
|
2.73991e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
2.73991e-05
|
|
|
naxos disease
|
[NCBI]
|
2.73991e-05
|
|
|
oguchi disease
|
[NCBI]
|
2.73991e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
2.73991e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
2.73991e-05
|
|
|
RP14
|
[NCBI]
|
2.73991e-05
|
|
|
fibular aplasia or hypoplasia, femoral bowing and poly-, syn-, and oligodactyly
|
[NCBI]
|
2.73991e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
2.73991e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
2.73991e-05
|
|
|
BDE
|
[NCBI]
|
2.73991e-05
|
|
|
ARVD2
|
[NCBI]
|
2.73991e-05
|
|
|
SHFM4
|
[NCBI]
|
2.73991e-05
|
|
|
BDA2
|
[NCBI]
|
2.73991e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
2.73991e-05
|
|
|
MONA
|
[NCBI]
|
2.73991e-05
|
|
|
SMDP2
|
[NCBI]
|
2.73991e-05
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
2.73991e-05
|
|
|
PLSDT
|
[NCBI]
|
2.73991e-05
|
|
|
fumarase deficiency
|
[NCBI]
|
2.73991e-05
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
2.73991e-05
|
|
|
RP13
|
[NCBI]
|
2.73991e-05
|
|
|
PVOD
|
[NCBI]
|
2.73991e-05
|
|
|
hyalinosis, infantile systemic
|
[NCBI]
|
2.73991e-05
|
|
|
minicore myopathy with external ophthalmoplegia
|
[NCBI]
|
2.73991e-05
|
|
|
tyrosinemia, type iii
|
[NCBI]
|
2.73991e-05
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
2.73991e-05
|
|
|
lung cancer
|
[NCBI]
|
2.71751e-05
|
|
|
HNFJ
|
[NCBI]
|
2.71751e-05
|
|
|
HSPB1
|
[NCBI]
|
2.70166e-05
|
|
|
A4GALT
|
[NCBI]
|
2.67585e-05
|
|
|
CDKL5
|
[NCBI]
|
2.67585e-05
|
|
|
KRT2A
|
[NCBI]
|
2.67585e-05
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
2.67585e-05
|
|
|
GBE1
|
[NCBI]
|
2.67585e-05
|
|
|
TGFBR2
|
[NCBI]
|
2.64746e-05
|
|
|
DPYD
|
[NCBI]
|
2.64746e-05
|
|
|
GAPDH
|
[NCBI]
|
2.64475e-05
|
|
|
MAS
|
[NCBI]
|
2.6252e-05
|
|
|
RCDP1
|
[NCBI]
|
2.59818e-05
|
|
|
IGF1R
|
[NCBI]
|
2.59519e-05
|
|
|
CAPN3
|
[NCBI]
|
2.59519e-05
|
|
|
WAS
|
[NCBI]
|
2.5819e-05
|
|
|
SGCG
|
[NCBI]
|
2.55537e-05
|
|
|
NAGS
|
[NCBI]
|
2.55537e-05
|
|
|
TGIF
|
[NCBI]
|
2.55537e-05
|
|
|
NPC1
|
[NCBI]
|
2.54717e-05
|
|
|
DYSF
|
[NCBI]
|
2.54472e-05
|
|
|
MC1R
|
[NCBI]
|
2.51024e-05
|
|
|
TYMS
|
[NCBI]
|
2.48924e-05
|
|
|
TF
|
[NCBI]
|
2.46857e-05
|
|
|
NR5A1
|
[NCBI]
|
2.45256e-05
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
2.44876e-05
|
|
|
MLC1
|
[NCBI]
|
2.44697e-05
|
|
|
DGUOK
|
[NCBI]
|
2.44697e-05
|
|
|
NLRP3
|
[NCBI]
|
2.44697e-05
|
|
|
PAX9
|
[NCBI]
|
2.44697e-05
|
|
|
C10ORF2
|
[NCBI]
|
2.44697e-05
|
|
|
TIMM8A
|
[NCBI]
|
2.44697e-05
|
|
|
BFSP2
|
[NCBI]
|
2.44697e-05
|
|
|
RP9
|
[NCBI]
|
2.44236e-05
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
2.44236e-05
|
|
|
foveal hypoplasia and presenile cataract syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
ulna and fibula, absence of, with severe limb deficiency
|
[NCBI]
|
2.44236e-05
|
|
|
HMS
|
[NCBI]
|
2.44236e-05
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
2.44236e-05
|
|
|
STHAG3
|
[NCBI]
|
2.44236e-05
|
|
|
xeroderma pigmentosum, complementation group e
|
[NCBI]
|
2.44236e-05
|
|
|
amme complex
|
[NCBI]
|
2.44236e-05
|
|
|
EJM1
|
[NCBI]
|
2.44236e-05
|
|
|
F5F8D
|
[NCBI]
|
2.44236e-05
|
|
|
lujan-fryns syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
three m syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
MPD1
|
[NCBI]
|
2.44236e-05
|
|
|
CORD3
|
[NCBI]
|
2.44236e-05
|
|
|
ALS4
|
[NCBI]
|
2.44236e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
2.44236e-05
|
|
|
CDG1C
|
[NCBI]
|
2.44236e-05
|
|
|
cataract-microcornea syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
2.44236e-05
|
|
|
winchester syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
aplastic anemia
|
[NCBI]
|
2.44236e-05
|
|
|
pierson syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
2.44236e-05
|
|
|
chromosome 16p13.3 deletion syndrome
|
[NCBI]
|
2.44236e-05
|
|
|
LQT1
|
[NCBI]
|
2.4023e-05
|
|
|
STGD1
|
[NCBI]
|
2.37691e-05
|
|
|
RP1
|
[NCBI]
|
2.37691e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
2.37691e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
2.37691e-05
|
|
|
ADA
|
[NCBI]
|
2.35914e-05
|
|
|
AVPR2
|
[NCBI]
|
2.35882e-05
|
|
|
RPS6KA3
|
[NCBI]
|
2.35882e-05
|
|
|
CLCN7
|
[NCBI]
|
2.34853e-05
|
|
|
LGI1
|
[NCBI]
|
2.34853e-05
|
|
|
HOS
|
[NCBI]
|
2.33284e-05
|
|
|
GK
|
[NCBI]
|
2.31591e-05
|
|
|
RAG1
|
[NCBI]
|
2.31591e-05
|
|
|
SHOX
|
[NCBI]
|
2.27426e-05
|
|
|
RUNX2
|
[NCBI]
|
2.27426e-05
|
|
|
CHEK2
|
[NCBI]
|
2.27426e-05
|
|
|
OPTN
|
[NCBI]
|
2.27426e-05
|
|
|
ACTG1
|
[NCBI]
|
2.25844e-05
|
|
|
CPT1A
|
[NCBI]
|
2.25844e-05
|
|
|
MPI
|
[NCBI]
|
2.25844e-05
|
|
|
TRAPPC2
|
[NCBI]
|
2.25844e-05
|
|
|
DUOX2
|
[NCBI]
|
2.25844e-05
|
|
|
EIF2B5
|
[NCBI]
|
2.25844e-05
|
|
|
NCF2
|
[NCBI]
|
2.25844e-05
|
|
|
IKBKAP
|
[NCBI]
|
2.25844e-05
|
|
|
MTP
|
[NCBI]
|
2.25844e-05
|
|
|
HGD
|
[NCBI]
|
2.25844e-05
|
|
|
PRPS1
|
[NCBI]
|
2.25844e-05
|
|
|
PKLR
|
[NCBI]
|
2.23382e-05
|
|
|
NR0B1
|
[NCBI]
|
2.23382e-05
|
|
|
RYR1
|
[NCBI]
|
2.20483e-05
|
|
|
prostate cancer
|
[NCBI]
|
2.19949e-05
|
|
|
GRN
|
[NCBI]
|
2.19453e-05
|
|
|
cystathioninuria
|
[NCBI]
|
2.19309e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
2.19309e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
2.19309e-05
|
|
|
opitz syndrome
|
[NCBI]
|
2.19309e-05
|
|
|
PHA2
|
[NCBI]
|
2.19309e-05
|
|
|
MFS2
|
[NCBI]
|
2.19309e-05
|
|
|
EBS-MP
|
[NCBI]
|
2.19309e-05
|
|
|
HRD
|
[NCBI]
|
2.19309e-05
|
|
|
KCS
|
[NCBI]
|
2.19309e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
2.19309e-05
|
|
|
DYT12
|
[NCBI]
|
2.19309e-05
|
|
|
PARK7
|
[NCBI]
|
2.19309e-05
|
|
|
HPS2
|
[NCBI]
|
2.19309e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
2.19309e-05
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
2.19309e-05
|
|
|
RP10
|
[NCBI]
|
2.19309e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
2.19309e-05
|
|
|
MCOPS2
|
[NCBI]
|
2.19309e-05
|
|
|
mal de meleda
|
[NCBI]
|
2.19309e-05
|
|
|
MCKD2
|
[NCBI]
|
2.19309e-05
|
|
|
ACHM3
|
[NCBI]
|
2.19309e-05
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
2.19309e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
2.19309e-05
|
|
|
AMDM
|
[NCBI]
|
2.19309e-05
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
2.19309e-05
|
|
|
hyperbilirubinemia, transient familial neonatal
|
[NCBI]
|
2.19309e-05
|
|
|
phenylketonuria
|
[NCBI]
|
2.18772e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
2.17615e-05
|
|
|
PCSK9
|
[NCBI]
|
2.17545e-05
|
|
|
NOTCH3
|
[NCBI]
|
2.17545e-05
|
|
|
ADAR
|
[NCBI]
|
2.17545e-05
|
|
|
FOXE1
|
[NCBI]
|
2.17545e-05
|
|
|
SCN2A
|
[NCBI]
|
2.17545e-05
|
|
|
IDUA
|
[NCBI]
|
2.12991e-05
|
|
|
SNCA
|
[NCBI]
|
2.12991e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
2.11917e-05
|
|
|
NAGLU
|
[NCBI]
|
2.09858e-05
|
|
|
BMPR2
|
[NCBI]
|
2.09858e-05
|
|
|
CVID
|
[NCBI]
|
2.09781e-05
|
|
|
SCN4A
|
[NCBI]
|
2.08299e-05
|
|
|
DJS
|
[NCBI]
|
2.08262e-05
|
|
|
gastric cancer
|
[NCBI]
|
2.08262e-05
|
|
|
SVAS
|
[NCBI]
|
2.07318e-05
|
|
|
TPO
|
[NCBI]
|
2.07003e-05
|
|
|
HBA2
|
[NCBI]
|
2.03396e-05
|
|
|
LAMA2
|
[NCBI]
|
2.02703e-05
|
|
|
SPG3A
|
[NCBI]
|
1.99327e-05
|
|
|
PARK2
|
[NCBI]
|
1.99327e-05
|
|
|
PGL1
|
[NCBI]
|
1.99327e-05
|
|
|
KRTHB5
|
[NCBI]
|
1.98552e-05
|
|
|
KRTHB3
|
[NCBI]
|
1.98552e-05
|
|
|
HYLS1
|
[NCBI]
|
1.98552e-05
|
|
|
MTMR7
|
[NCBI]
|
1.98552e-05
|
|
|
ichthyin
|
[NCBI]
|
1.98552e-05
|
|
|
TBX20
|
[NCBI]
|
1.98552e-05
|
|
|
CNKSR1
|
[NCBI]
|
1.98552e-05
|
|
|
hormone-regulated proliferation-associated protein, 20-kd
|
[NCBI]
|
1.98552e-05
|
|
|
BBS7
|
[NCBI]
|
1.98552e-05
|
|
|
SLC35A3
|
[NCBI]
|
1.98552e-05
|
|
|
PTPN14
|
[NCBI]
|
1.98552e-05
|
|
|
RAX
|
[NCBI]
|
1.98552e-05
|
|
|
MMAA
|
[NCBI]
|
1.98552e-05
|
|
|
RUSC2
|
[NCBI]
|
1.98552e-05
|
|
|
OPA3
|
[NCBI]
|
1.98552e-05
|
|
|
MTMR6
|
[NCBI]
|
1.98552e-05
|
|
|
MASTL
|
[NCBI]
|
1.98552e-05
|
|
|
PTPLA
|
[NCBI]
|
1.98552e-05
|
|
|
RC3H1
|
[NCBI]
|
1.98552e-05
|
|
|
ATRX
|
[NCBI]
|
1.97997e-05
|
|
|
currarino syndrome
|
[NCBI]
|
1.97992e-05
|
|
|
osteogenic sarcoma
|
[NCBI]
|
1.97992e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
1.97992e-05
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
1.97992e-05
|
|
|
FTC
|
[NCBI]
|
1.97992e-05
|
|
|
c syndrome
|
[NCBI]
|
1.97992e-05
|
|
|
DFNA9
|
[NCBI]
|
1.97992e-05
|
|
|
FTD3
|
[NCBI]
|
1.97992e-05
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
1.97992e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
1.97992e-05
|
|
|
EDM4
|
[NCBI]
|
1.97992e-05
|
|
|
CLPED1
|
[NCBI]
|
1.97992e-05
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
1.97992e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
1.97992e-05
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
1.97992e-05
|
|
|
DDD
|
[NCBI]
|
1.97992e-05
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
1.97992e-05
|
|
|
morquio syndrome b
|
[NCBI]
|
1.97992e-05
|
|
|
crigler-najjar syndrome, type ii
|
[NCBI]
|
1.97992e-05
|
|
|
AML
|
[NCBI]
|
1.97992e-05
|
|
|
CMT2D
|
[NCBI]
|
1.97992e-05
|
|
|
MAN2B1
|
[NCBI]
|
1.96016e-05
|
|
|
SLC45A2
|
[NCBI]
|
1.96016e-05
|
|
|
FGB
|
[NCBI]
|
1.96016e-05
|
|
|
EIG
|
[NCBI]
|
1.95897e-05
|
|
|
COL7A1
|
[NCBI]
|
1.91548e-05
|
|
|
HCH
|
[NCBI]
|
1.90784e-05
|
|
|
NEFL
|
[NCBI]
|
1.89743e-05
|
|
|
TPM3
|
[NCBI]
|
1.89743e-05
|
|
|
FOXC1
|
[NCBI]
|
1.89743e-05
|
|
|
GLUD1
|
[NCBI]
|
1.89743e-05
|
|
|
TGFBR1
|
[NCBI]
|
1.89743e-05
|
|
|
GLDC
|
[NCBI]
|
1.89743e-05
|
|
|
RAF1
|
[NCBI]
|
1.89743e-05
|
|
|
COL2A1
|
[NCBI]
|
1.86144e-05
|
|
|
HNF1A
|
[NCBI]
|
1.84106e-05
|
|
|
G6PT1
|
[NCBI]
|
1.83838e-05
|
|
|
SGCE
|
[NCBI]
|
1.83838e-05
|
|
|
KCNJ2
|
[NCBI]
|
1.83838e-05
|
|
|
PTPN22
|
[NCBI]
|
1.83838e-05
|
|
|
ECM1
|
[NCBI]
|
1.83838e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
1.82609e-05
|
|
|
CADASIL
|
[NCBI]
|
1.82609e-05
|
|
|
GCK
|
[NCBI]
|
1.82096e-05
|
|
|
F13A1
|
[NCBI]
|
1.7954e-05
|
|
|
FH
|
[NCBI]
|
1.7954e-05
|
|
|
XPG
|
[NCBI]
|
1.79477e-05
|
|
|
CZP1
|
[NCBI]
|
1.79477e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
1.79477e-05
|
|
|
PKD3
|
[NCBI]
|
1.79477e-05
|
|
|
LGMD2E
|
[NCBI]
|
1.79477e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
1.79477e-05
|
|
|
ATLD
|
[NCBI]
|
1.79477e-05
|
|
|
CDB1
|
[NCBI]
|
1.79477e-05
|
|
|
situs inversus viscerum
|
[NCBI]
|
1.79477e-05
|
|
|
JWS
|
[NCBI]
|
1.79477e-05
|
|
|
CTLN2
|
[NCBI]
|
1.79477e-05
|
|
|
SPG17
|
[NCBI]
|
1.79477e-05
|
|
|
CLN8
|
[NCBI]
|
1.79477e-05
|
|
|
SMMCI
|
[NCBI]
|
1.79477e-05
|
|
|
DFNA2
|
[NCBI]
|
1.79477e-05
|
|
|
FMD
|
[NCBI]
|
1.79477e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.7853e-05
|
|
|
GALK1
|
[NCBI]
|
1.78265e-05
|
|
|
PHOX2B
|
[NCBI]
|
1.78265e-05
|
|
|
CMTX1
|
[NCBI]
|
1.74781e-05
|
|
|
OPA1
|
[NCBI]
|
1.74781e-05
|
|
|
MEB
|
[NCBI]
|
1.74781e-05
|
|
|
WFS1
|
[NCBI]
|
1.74781e-05
|
|
|
LHCGR
|
[NCBI]
|
1.73936e-05
|
|
|
ALS1
|
[NCBI]
|
1.73211e-05
|
|
|
DSP
|
[NCBI]
|
1.7299e-05
|
|
|
CLN3
|
[NCBI]
|
1.7299e-05
|
|
|
CTSD
|
[NCBI]
|
1.7299e-05
|
|
|
WIPF1
|
[NCBI]
|
1.7299e-05
|
|
|
APC
|
[NCBI]
|
1.71383e-05
|
|
|
KRT1
|
[NCBI]
|
1.67986e-05
|
|
|
PIK3CA
|
[NCBI]
|
1.67986e-05
|
|
|
GHSR
|
[NCBI]
|
1.67986e-05
|
|
|
HOXD13
|
[NCBI]
|
1.67986e-05
|
|
|
AMPD1
|
[NCBI]
|
1.67986e-05
|
|
|
GATA4
|
[NCBI]
|
1.67986e-05
|
|
|
CYP27B1
|
[NCBI]
|
1.67986e-05
|
|
|
EBP
|
[NCBI]
|
1.67986e-05
|
|
|
PSAT1
|
[NCBI]
|
1.67957e-05
|
|
|
ATP13A2
|
[NCBI]
|
1.67957e-05
|
|
|
MYOZ2
|
[NCBI]
|
1.67957e-05
|
|
|
PTPRT
|
[NCBI]
|
1.67957e-05
|
|
|
UNC93B1
|
[NCBI]
|
1.67957e-05
|
|
|
CCT4
|
[NCBI]
|
1.67957e-05
|
|
|
deleted in breast cancer 1
|
[NCBI]
|
1.67957e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.67957e-05
|
|
|
TPST2
|
[NCBI]
|
1.67957e-05
|
|
|
THRAP2
|
[NCBI]
|
1.67957e-05
|
|
|
DMGDH
|
[NCBI]
|
1.67957e-05
|
|
|
CD96
|
[NCBI]
|
1.67957e-05
|
|
|
nebulette
|
[NCBI]
|
1.67957e-05
|
|
|
TMEM16E
|
[NCBI]
|
1.67957e-05
|
|
|
GNPTG
|
[NCBI]
|
1.67957e-05
|
|
|
SYT11
|
[NCBI]
|
1.67957e-05
|
|
|
CIRH1A
|
[NCBI]
|
1.67957e-05
|
|
|
PLEKHG5
|
[NCBI]
|
1.67957e-05
|
|
|
CTH
|
[NCBI]
|
1.67957e-05
|
|
|
NEUROD4
|
[NCBI]
|
1.67957e-05
|
|
|
d-2-@hydroxyglutarate dehydrogenase
|
[NCBI]
|
1.67957e-05
|
|
|
AKR1D1
|
[NCBI]
|
1.67957e-05
|
|
|
HISPPD1
|
[NCBI]
|
1.67957e-05
|
|
|
SMARCAL1
|
[NCBI]
|
1.67957e-05
|
|
|
PEX10
|
[NCBI]
|
1.67957e-05
|
|
|
RAB3GAP2
|
[NCBI]
|
1.67957e-05
|
|
|
EIF4E2
|
[NCBI]
|
1.67957e-05
|
|
|
ZNF365
|
[NCBI]
|
1.67957e-05
|
|
|
KRT6B
|
[NCBI]
|
1.67957e-05
|
|
|
C14ORF58
|
[NCBI]
|
1.67957e-05
|
|
|
PSEN2
|
[NCBI]
|
1.65975e-05
|
|
|
SRY
|
[NCBI]
|
1.65149e-05
|
|
|
TYR
|
[NCBI]
|
1.65149e-05
|
|
|
RPGR
|
[NCBI]
|
1.63432e-05
|
|
|
TCOF1
|
[NCBI]
|
1.63229e-05
|
|
|
NR3C2
|
[NCBI]
|
1.63229e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.63229e-05
|
|
|
BDC
|
[NCBI]
|
1.63201e-05
|
|
|
SPG6
|
[NCBI]
|
1.63201e-05
|
|
|
ASMD
|
[NCBI]
|
1.63201e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
1.63201e-05
|
|
|
BDA1
|
[NCBI]
|
1.63201e-05
|
|
|
HNPCC2
|
[NCBI]
|
1.63201e-05
|
|
|
SCAR1
|
[NCBI]
|
1.63201e-05
|
|
|
BOS1
|
[NCBI]
|
1.63201e-05
|
|
|
wagr syndrome
|
[NCBI]
|
1.63201e-05
|
|
|
IRID2
|
[NCBI]
|
1.63201e-05
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
1.63201e-05
|
|
|
CDL1
|
[NCBI]
|
1.63201e-05
|
|
|
Ii
|
[NCBI]
|
1.63201e-05
|
|
|
myeloperoxidase deficiency
|
[NCBI]
|
1.63201e-05
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
1.63201e-05
|
|
|
DRRS
|
[NCBI]
|
1.63201e-05
|
|
|
XPV
|
[NCBI]
|
1.63201e-05
|
|
|
DFNA12
|
[NCBI]
|
1.63201e-05
|
|
|
GLC1A
|
[NCBI]
|
1.60091e-05
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
1.60091e-05
|
|
|
HYPP
|
[NCBI]
|
1.60091e-05
|
|
|
aHUS
|
[NCBI]
|
1.60091e-05
|
|
|
EMD
|
[NCBI]
|
1.58697e-05
|
|
|
MFN2
|
[NCBI]
|
1.58697e-05
|
|
|
PINK1
|
[NCBI]
|
1.58697e-05
|
|
|
LHB
|
[NCBI]
|
1.58697e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.58697e-05
|
|
|
SOD2
|
[NCBI]
|
1.54673e-05
|
|
|
FGFR4
|
[NCBI]
|
1.54372e-05
|
|
|
KLF6
|
[NCBI]
|
1.54372e-05
|
|
|
MYH9
|
[NCBI]
|
1.54372e-05
|
|
|
NF2
|
[NCBI]
|
1.53766e-05
|
|
|
HHF1
|
[NCBI]
|
1.53193e-05
|
|
|
CACNA1C
|
[NCBI]
|
1.50238e-05
|
|
|
ELA2
|
[NCBI]
|
1.50238e-05
|
|
|
pta deficiency
|
[NCBI]
|
1.50238e-05
|
|
|
UGT1A1
|
[NCBI]
|
1.49213e-05
|
|
|
THC1
|
[NCBI]
|
1.48755e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
1.48755e-05
|
|
|
plasminogen deficiency, type i
|
[NCBI]
|
1.48755e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
1.48755e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.48755e-05
|
|
|
ALUNC
|
[NCBI]
|
1.48755e-05
|
|
|
MCDC1
|
[NCBI]
|
1.48755e-05
|
|
|
LGMD2D
|
[NCBI]
|
1.48755e-05
|
|
|
DA2B
|
[NCBI]
|
1.48755e-05
|
|
|
MERRF
|
[NCBI]
|
1.48755e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
1.48755e-05
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
1.48755e-05
|
|
|
CLN5
|
[NCBI]
|
1.48755e-05
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
1.48755e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
1.48755e-05
|
|
|
CMT2B
|
[NCBI]
|
1.48755e-05
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
1.48755e-05
|
|
|
medulloblastoma
|
[NCBI]
|
1.48755e-05
|
|
|
XPF
|
[NCBI]
|
1.48755e-05
|
|
|
SBF1
|
[NCBI]
|
1.48277e-05
|
|
|
EXTL1
|
[NCBI]
|
1.48277e-05
|
|
|
PEX26
|
[NCBI]
|
1.48277e-05
|
|
|
CSRP3
|
[NCBI]
|
1.48277e-05
|
|
|
ALG3
|
[NCBI]
|
1.48277e-05
|
|
|
CYP4F12
|
[NCBI]
|
1.48277e-05
|
|
|
RHOBTB2
|
[NCBI]
|
1.48277e-05
|
|
|
HISPPD2A
|
[NCBI]
|
1.48277e-05
|
|
|
TCAP
|
[NCBI]
|
1.48277e-05
|
|
|
EFEMP2
|
[NCBI]
|
1.48277e-05
|
|
|
GCS1
|
[NCBI]
|
1.48277e-05
|
|
|
ZNF350
|
[NCBI]
|
1.48277e-05
|
|
|
COL8A2
|
[NCBI]
|
1.48277e-05
|
|
|
NKX2-6
|
[NCBI]
|
1.48277e-05
|
|
|
PNPO
|
[NCBI]
|
1.48277e-05
|
|
|
CSNK1D
|
[NCBI]
|
1.48277e-05
|
|
|
MTMR4
|
[NCBI]
|
1.48277e-05
|
|
|
CXORF6
|
[NCBI]
|
1.48277e-05
|
|
|
SLC12A6
|
[NCBI]
|
1.48277e-05
|
|
|
RP9
|
[NCBI]
|
1.48277e-05
|
|
|
STRA6
|
[NCBI]
|
1.48277e-05
|
|
|
PTPN3
|
[NCBI]
|
1.48277e-05
|
|
|
CLN5
|
[NCBI]
|
1.48277e-05
|
|
|
NEF3
|
[NCBI]
|
1.48277e-05
|
|
|
ALG1
|
[NCBI]
|
1.48277e-05
|
|
|
alg8, s. cerevisiae, homolog of
|
[NCBI]
|
1.48277e-05
|
|
|
PRPF8
|
[NCBI]
|
1.48277e-05
|
|
|
LRP4
|
[NCBI]
|
1.48277e-05
|
|
|
SOX18
|
[NCBI]
|
1.48277e-05
|
|
|
LRP1B
|
[NCBI]
|
1.48277e-05
|
|
|
ELN
|
[NCBI]
|
1.47002e-05
|
|
|
MTS
|
[NCBI]
|
1.46574e-05
|
|
|
GJA5
|
[NCBI]
|
1.46281e-05
|
|
|
CRYAB
|
[NCBI]
|
1.46281e-05
|
|
|
CTSK
|
[NCBI]
|
1.46281e-05
|
|
|
EYA1
|
[NCBI]
|
1.46281e-05
|
|
|
MVK
|
[NCBI]
|
1.46281e-05
|
|
|
POMC
|
[NCBI]
|
1.44807e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.44046e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.43663e-05
|
|
|
PYY
|
[NCBI]
|
1.43428e-05
|
|
|
MUT
|
[NCBI]
|
1.42487e-05
|
|
|
ABCC8
|
[NCBI]
|
1.42307e-05
|
|
|
PPARG
|
[NCBI]
|
1.40816e-05
|
|
|
RSTS
|
[NCBI]
|
1.40218e-05
|
|
|
FA
|
[NCBI]
|
1.40046e-05
|
|
|
NOG
|
[NCBI]
|
1.38845e-05
|
|
|
APP
|
[NCBI]
|
1.37026e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
1.35832e-05
|
|
|
MCDS
|
[NCBI]
|
1.35832e-05
|
|
|
ACCPN
|
[NCBI]
|
1.35832e-05
|
|
|
THC2
|
[NCBI]
|
1.35832e-05
|
|
|
EDM1
|
[NCBI]
|
1.35832e-05
|
|
|
septooptic dysplasia
|
[NCBI]
|
1.35832e-05
|
|
|
XPD
|
[NCBI]
|
1.35832e-05
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
1.35832e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
1.35832e-05
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
1.35832e-05
|
|
|
GJB1
|
[NCBI]
|
1.35023e-05
|
|
|
MMP20
|
[NCBI]
|
1.3378e-05
|
|
|
PALB2
|
[NCBI]
|
1.3378e-05
|
|
|
UBE2L3
|
[NCBI]
|
1.3378e-05
|
|
|
HTRA2
|
[NCBI]
|
1.3378e-05
|
|
|
OPTC
|
[NCBI]
|
1.3378e-05
|
|
|
CLCNKA
|
[NCBI]
|
1.3378e-05
|
|
|
GCM2
|
[NCBI]
|
1.3378e-05
|
|
|
MTMR3
|
[NCBI]
|
1.3378e-05
|
|
|
TGM5
|
[NCBI]
|
1.3378e-05
|
|
|
CHRNA2
|
[NCBI]
|
1.3378e-05
|
|
|
CRYGS
|
[NCBI]
|
1.3378e-05
|
|
|
BFSP1
|
[NCBI]
|
1.3378e-05
|
|
|
NDUFV1
|
[NCBI]
|
1.3378e-05
|
|
|
KCNC3
|
[NCBI]
|
1.3378e-05
|
|
|
ABCA12
|
[NCBI]
|
1.3378e-05
|
|
|
PLOD2
|
[NCBI]
|
1.3378e-05
|
|
|
PHF6
|
[NCBI]
|
1.3378e-05
|
|
|
CABP4
|
[NCBI]
|
1.3378e-05
|
|
|
CCT5
|
[NCBI]
|
1.3378e-05
|
|
|
VAPB
|
[NCBI]
|
1.3378e-05
|
|
|
CUL7
|
[NCBI]
|
1.3378e-05
|
|
|
FUT7
|
[NCBI]
|
1.3378e-05
|
|
|
PEX3
|
[NCBI]
|
1.3378e-05
|
|
|
feline leukemia virus subgroup c receptor
|
[NCBI]
|
1.3378e-05
|
|
|
IRAK3
|
[NCBI]
|
1.3378e-05
|
|
|
SMAX1
|
[NCBI]
|
1.32173e-05
|
|
|
NPC1
|
[NCBI]
|
1.31978e-05
|
|
|
SPINK1
|
[NCBI]
|
1.30846e-05
|
|
|
ERCC2
|
[NCBI]
|
1.28734e-05
|
|
|
FTL
|
[NCBI]
|
1.28734e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.28734e-05
|
|
|
ALDH3A2
|
[NCBI]
|
1.28734e-05
|
|
|
GCH1
|
[NCBI]
|
1.28734e-05
|
|
|
SLC40A1
|
[NCBI]
|
1.28734e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
1.28246e-05
|
|
|
ARSA
|
[NCBI]
|
1.26991e-05
|
|
|
COL10A1
|
[NCBI]
|
1.25607e-05
|
|
|
LQT3
|
[NCBI]
|
1.24198e-05
|
|
|
JME
|
[NCBI]
|
1.24198e-05
|
|
|
COFS1
|
[NCBI]
|
1.24198e-05
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
1.24198e-05
|
|
|
BHD
|
[NCBI]
|
1.24198e-05
|
|
|
SPD1
|
[NCBI]
|
1.24198e-05
|
|
|
ARMD4
|
[NCBI]
|
1.24198e-05
|
|
|
sitosterolemia
|
[NCBI]
|
1.24198e-05
|
|
|
JLNS1
|
[NCBI]
|
1.24198e-05
|
|
|
ARVD1
|
[NCBI]
|
1.24198e-05
|
|
|
PPS
|
[NCBI]
|
1.24198e-05
|
|
|
ACHM2
|
[NCBI]
|
1.24198e-05
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
1.24198e-05
|
|
|
OPD2
|
[NCBI]
|
1.24198e-05
|
|
|
CFEOM1
|
[NCBI]
|
1.24198e-05
|
|
|
STGD3
|
[NCBI]
|
1.24198e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
1.24198e-05
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
1.24198e-05
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
1.24198e-05
|
|
|
JBS
|
[NCBI]
|
1.24198e-05
|
|
|
ABL
|
[NCBI]
|
1.22607e-05
|
|
|
CFI
|
[NCBI]
|
1.22589e-05
|
|
|
BBS
|
[NCBI]
|
1.22389e-05
|
|
|
GFRA2
|
[NCBI]
|
1.22336e-05
|
|
|
TEAD1
|
[NCBI]
|
1.22336e-05
|
|
|
MFRP
|
[NCBI]
|
1.22336e-05
|
|
|
NLGN4
|
[NCBI]
|
1.22336e-05
|
|
|
MAD1L1
|
[NCBI]
|
1.22336e-05
|
|
|
VANGL1
|
[NCBI]
|
1.22336e-05
|
|
|
HSD17B3
|
[NCBI]
|
1.22336e-05
|
|
|
MTMR1
|
[NCBI]
|
1.22336e-05
|
|
|
LSS
|
[NCBI]
|
1.22336e-05
|
|
|
TNNT3
|
[NCBI]
|
1.22336e-05
|
|
|
SEMA3E
|
[NCBI]
|
1.22336e-05
|
|
|
BCOR
|
[NCBI]
|
1.22336e-05
|
|
|
HCN4
|
[NCBI]
|
1.22336e-05
|
|
|
SLC35C1
|
[NCBI]
|
1.22336e-05
|
|
|
MTTF
|
[NCBI]
|
1.22336e-05
|
|
|
GRK1
|
[NCBI]
|
1.22336e-05
|
|
|
NIPA1
|
[NCBI]
|
1.22336e-05
|
|
|
ATP1A3
|
[NCBI]
|
1.22336e-05
|
|
|
BBS1
|
[NCBI]
|
1.22336e-05
|
|
|
FDXR
|
[NCBI]
|
1.22336e-05
|
|
|
ALG6
|
[NCBI]
|
1.22336e-05
|
|
|
GRM6
|
[NCBI]
|
1.22336e-05
|
|
|
TSHR
|
[NCBI]
|
1.19917e-05
|
|
|
ERCC5
|
[NCBI]
|
1.19674e-05
|
|
|
FGFR1
|
[NCBI]
|
1.19115e-05
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.17921e-05
|
|
|
BRCA2
|
[NCBI]
|
1.17881e-05
|
|
|
SCS
|
[NCBI]
|
1.17185e-05
|
|
|
GDF5
|
[NCBI]
|
1.16857e-05
|
|
|
STAT5B
|
[NCBI]
|
1.16857e-05
|
|
|
OA1
|
[NCBI]
|
1.16857e-05
|
|
|
INSR
|
[NCBI]
|
1.16659e-05
|
|
|
JMML
|
[NCBI]
|
1.15146e-05
|
|
|
wilson disease
|
[NCBI]
|
1.15146e-05
|
|
|
PHEX
|
[NCBI]
|
1.14131e-05
|
|
|
coproporphyria
|
[NCBI]
|
1.14131e-05
|
|
|
PTHR1
|
[NCBI]
|
1.14131e-05
|
|
|
GATA1
|
[NCBI]
|
1.14131e-05
|
|
|
UMS
|
[NCBI]
|
1.13668e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
1.13668e-05
|
|
|
CTHM
|
[NCBI]
|
1.13668e-05
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
1.13668e-05
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
1.13668e-05
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
1.13668e-05
|
|
|
SCZD4
|
[NCBI]
|
1.13668e-05
|
|
|
muckle-wells syndrome
|
[NCBI]
|
1.13668e-05
|
|
|
glutaric acidemia i
|
[NCBI]
|
1.13668e-05
|
|
|
propionic acidemia
|
[NCBI]
|
1.13668e-05
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
1.13668e-05
|
|
|
CDG2C
|
[NCBI]
|
1.13668e-05
|
|
|
HPE3
|
[NCBI]
|
1.13668e-05
|
|
|
MTHFR
|
[NCBI]
|
1.13295e-05
|
|
|
NHS
|
[NCBI]
|
1.1291e-05
|
|
|
MDM4
|
[NCBI]
|
1.1291e-05
|
|
|
TUBA1A
|
[NCBI]
|
1.1291e-05
|
|
|
ROBO2
|
[NCBI]
|
1.1291e-05
|
|
|
ESCO2
|
[NCBI]
|
1.1291e-05
|
|
|
HSF4
|
[NCBI]
|
1.1291e-05
|
|
|
NDUFS8
|
[NCBI]
|
1.1291e-05
|
|
|
TBX22
|
[NCBI]
|
1.1291e-05
|
|
|
SEMA4A
|
[NCBI]
|
1.1291e-05
|
|
|
PLCE1
|
[NCBI]
|
1.1291e-05
|
|
|
SUFU
|
[NCBI]
|
1.1291e-05
|
|
|
KRT6A
|
[NCBI]
|
1.1291e-05
|
|
|
NSDHL
|
[NCBI]
|
1.1291e-05
|
|
|
DYX1C1
|
[NCBI]
|
1.1291e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
1.1291e-05
|
|
|
ALDH5A1
|
[NCBI]
|
1.1291e-05
|
|
|
GNA11
|
[NCBI]
|
1.1291e-05
|
|
|
WISP3
|
[NCBI]
|
1.1291e-05
|
|
|
HMGCS2
|
[NCBI]
|
1.1291e-05
|
|
|
CLN8
|
[NCBI]
|
1.1291e-05
|
|
|
CHMP4B
|
[NCBI]
|
1.1291e-05
|
|
|
HSPB8
|
[NCBI]
|
1.1291e-05
|
|
|
PTPN13
|
[NCBI]
|
1.1291e-05
|
|
|
HOXD10
|
[NCBI]
|
1.1291e-05
|
|
|
ANK3
|
[NCBI]
|
1.1291e-05
|
|
|
SCA6
|
[NCBI]
|
1.1197e-05
|
|
|
LWD
|
[NCBI]
|
1.1197e-05
|
|
|
ASPA
|
[NCBI]
|
1.11492e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
1.11492e-05
|
|
|
EGFR
|
[NCBI]
|
1.10309e-05
|
|
|
PJS
|
[NCBI]
|
1.08574e-05
|
|
|
ACE
|
[NCBI]
|
1.08474e-05
|
|
|
BWS
|
[NCBI]
|
1.07217e-05
|
|
|
CMT1B
|
[NCBI]
|
1.06953e-05
|
|
|
GAMT
|
[NCBI]
|
1.06458e-05
|
|
|
NLGN3
|
[NCBI]
|
1.04917e-05
|
|
|
NIPBL
|
[NCBI]
|
1.04917e-05
|
|
|
SNCB
|
[NCBI]
|
1.04917e-05
|
|
|
TNNC1
|
[NCBI]
|
1.04917e-05
|
|
|
DCLRE1C
|
[NCBI]
|
1.04917e-05
|
|
|
HLXB9
|
[NCBI]
|
1.04917e-05
|
|
|
LAMB2
|
[NCBI]
|
1.04917e-05
|
|
|
ISL1
|
[NCBI]
|
1.04917e-05
|
|
|
IFNGR2
|
[NCBI]
|
1.04917e-05
|
|
|
TRPM7
|
[NCBI]
|
1.04917e-05
|
|
|
PEX6
|
[NCBI]
|
1.04917e-05
|
|
|
COL9A3
|
[NCBI]
|
1.04917e-05
|
|
|
PTPRG
|
[NCBI]
|
1.04917e-05
|
|
|
SEPN1
|
[NCBI]
|
1.04917e-05
|
|
|
VKORC1
|
[NCBI]
|
1.04917e-05
|
|
|
LGR8
|
[NCBI]
|
1.04917e-05
|
|
|
PICALM
|
[NCBI]
|
1.04917e-05
|
|
|
PRPF31
|
[NCBI]
|
1.04917e-05
|
|
|
PODXL
|
[NCBI]
|
1.04917e-05
|
|
|
BMPR1B
|
[NCBI]
|
1.04917e-05
|
|
|
NT5C3
|
[NCBI]
|
1.04917e-05
|
|
|
CHMP2B
|
[NCBI]
|
1.04917e-05
|
|
|
ROBO1
|
[NCBI]
|
1.04917e-05
|
|
|
SLC25A13
|
[NCBI]
|
1.04917e-05
|
|
|
PSPH
|
[NCBI]
|
1.04917e-05
|
|
|
FANCE
|
[NCBI]
|
1.04917e-05
|
|
|
CNGA3
|
[NCBI]
|
1.04917e-05
|
|
|
CYP4A11
|
[NCBI]
|
1.04917e-05
|
|
|
BCS1L
|
[NCBI]
|
1.04917e-05
|
|
|
SLC22A4
|
[NCBI]
|
1.04917e-05
|
|
|
ACVR2B
|
[NCBI]
|
1.04917e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
1.04094e-05
|
|
|
PFIC1
|
[NCBI]
|
1.04094e-05
|
|
|
CMDD
|
[NCBI]
|
1.04094e-05
|
|
|
DLB
|
[NCBI]
|
1.04094e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
1.04094e-05
|
|
|
GSD
|
[NCBI]
|
1.04094e-05
|
|
|
coumarin resistance
|
[NCBI]
|
1.04094e-05
|
|
|
STK11
|
[NCBI]
|
1.04055e-05
|
|
|
COMP
|
[NCBI]
|
1.03954e-05
|
|
|
TP53
|
[NCBI]
|
1.03412e-05
|
|
|
galactosemia
|
[NCBI]
|
1.02125e-05
|
|
|
GAA
|
[NCBI]
|
1.01723e-05
|
|
|
SMN1
|
[NCBI]
|
9.98404e-06
|
|
|
ABCA4
|
[NCBI]
|
9.94577e-06
|
|
|
SEMA7A
|
[NCBI]
|
9.79962e-06
|
|
|
ABCG8
|
[NCBI]
|
9.79962e-06
|
|
|
ANTXR2
|
[NCBI]
|
9.79962e-06
|
|
|
COL9A2
|
[NCBI]
|
9.79962e-06
|
|
|
DYNC1H1
|
[NCBI]
|
9.79962e-06
|
|
|
SIP1
|
[NCBI]
|
9.79962e-06
|
|
|
SOD3
|
[NCBI]
|
9.79962e-06
|
|
|
PEX13
|
[NCBI]
|
9.79962e-06
|
|
|
MTRR
|
[NCBI]
|
9.79962e-06
|
|
|
HCF2
|
[NCBI]
|
9.79962e-06
|
|
|
FRZB
|
[NCBI]
|
9.79962e-06
|
|
|
MEN1
|
[NCBI]
|
9.70926e-06
|
|
|
MKKS
|
[NCBI]
|
9.53569e-06
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
9.53569e-06
|
|
|
refsum disease
|
[NCBI]
|
9.53569e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
9.53569e-06
|
|
|
RSMD1
|
[NCBI]
|
9.53569e-06
|
|
|
CORD2
|
[NCBI]
|
9.53569e-06
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
9.53569e-06
|
|
|
ICP
|
[NCBI]
|
9.53569e-06
|
|
|
HPC1
|
[NCBI]
|
9.53569e-06
|
|
|
alkaptonuria
|
[NCBI]
|
9.53569e-06
|
|
|
AHDS
|
[NCBI]
|
9.53569e-06
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
9.53569e-06
|
|
|
SPG2
|
[NCBI]
|
9.53569e-06
|
|
|
SOX9
|
[NCBI]
|
9.5118e-06
|
|
|
FCMD
|
[NCBI]
|
9.30078e-06
|
|
|
TRPC6
|
[NCBI]
|
9.19077e-06
|
|
|
HPD
|
[NCBI]
|
9.19077e-06
|
|
|
PTPRF
|
[NCBI]
|
9.19077e-06
|
|
|
MLPH
|
[NCBI]
|
9.19077e-06
|
|
|
KRTHB6
|
[NCBI]
|
9.19077e-06
|
|
|
ZFPM2
|
[NCBI]
|
9.19077e-06
|
|
|
CDH3
|
[NCBI]
|
9.19077e-06
|
|
|
MAP2K2
|
[NCBI]
|
9.19077e-06
|
|
|
OSMR
|
[NCBI]
|
9.19077e-06
|
|
|
ING1
|
[NCBI]
|
9.19077e-06
|
|
|
PHYH
|
[NCBI]
|
9.19077e-06
|
|
|
CLDN16
|
[NCBI]
|
9.19077e-06
|
|
|
FGF5
|
[NCBI]
|
9.19077e-06
|
|
|
WNT4
|
[NCBI]
|
9.19077e-06
|
|
|
SCO2
|
[NCBI]
|
9.19077e-06
|
|
|
HAL
|
[NCBI]
|
9.19077e-06
|
|
|
AKT2
|
[NCBI]
|
9.19077e-06
|
|
|
ATP8B1
|
[NCBI]
|
9.19077e-06
|
|
|
ZIC2
|
[NCBI]
|
9.19077e-06
|
|
|
LITAF
|
[NCBI]
|
9.19077e-06
|
|
|
WNT7A
|
[NCBI]
|
9.19077e-06
|
|
|
DSG4
|
[NCBI]
|
9.19077e-06
|
|
|
ANKH
|
[NCBI]
|
9.19077e-06
|
|
|
VCL
|
[NCBI]
|
9.19077e-06
|
|
|
GCNT2
|
[NCBI]
|
9.19077e-06
|
|
|
TACSTD2
|
[NCBI]
|
9.19077e-06
|
|
|
IMPDH1
|
[NCBI]
|
9.19077e-06
|
|
|
PPARA
|
[NCBI]
|
9.18104e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
9.10138e-06
|
|
|
MTATP6
|
[NCBI]
|
9.10138e-06
|
|
|
CASR
|
[NCBI]
|
8.98767e-06
|
|
|
AIRE
|
[NCBI]
|
8.93163e-06
|
|
|
CREBBP
|
[NCBI]
|
8.90437e-06
|
|
|
factor x deficiency
|
[NCBI]
|
8.90437e-06
|
|
|
TSC1
|
[NCBI]
|
8.90437e-06
|
|
|
HBB
|
[NCBI]
|
8.84901e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
8.73575e-06
|
|
|
BGS
|
[NCBI]
|
8.73575e-06
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
8.73575e-06
|
|
|
MNS
|
[NCBI]
|
8.73575e-06
|
|
|
GABEB
|
[NCBI]
|
8.73575e-06
|
|
|
bladder cancer
|
[NCBI]
|
8.73575e-06
|
|
|
FTLDU
|
[NCBI]
|
8.73575e-06
|
|
|
ACADM
|
[NCBI]
|
8.70884e-06
|
|
|
SECISBP2
|
[NCBI]
|
8.64839e-06
|
|
|
KERA
|
[NCBI]
|
8.64839e-06
|
|
|
CYP27A1
|
[NCBI]
|
8.64839e-06
|
|
|
RPA1
|
[NCBI]
|
8.64839e-06
|
|
|
ZMPSTE24
|
[NCBI]
|
8.64839e-06
|
|
|
GP9
|
[NCBI]
|
8.64839e-06
|
|
|
FACL4
|
[NCBI]
|
8.64839e-06
|
|
|
HSD17B10
|
[NCBI]
|
8.64839e-06
|
|
|
ATP2B2
|
[NCBI]
|
8.64839e-06
|
|
|
LRP6
|
[NCBI]
|
8.64839e-06
|
|
|
PRND
|
[NCBI]
|
8.64839e-06
|
|
|
BARD1
|
[NCBI]
|
8.64839e-06
|
|
|
NR2E3
|
[NCBI]
|
8.64839e-06
|
|
|
HESX1
|
[NCBI]
|
8.64839e-06
|
|
|
LIM2
|
[NCBI]
|
8.64839e-06
|
|
|
FGD1
|
[NCBI]
|
8.64839e-06
|
|
|
KCNMB1
|
[NCBI]
|
8.64839e-06
|
|
|
POMGNT1
|
[NCBI]
|
8.64839e-06
|
|
|
NTRK1
|
[NCBI]
|
8.52565e-06
|
|
|
ARPKD
|
[NCBI]
|
8.45588e-06
|
|
|
PGR
|
[NCBI]
|
8.43253e-06
|
|
|
GNAS
|
[NCBI]
|
8.33261e-06
|
|
|
SH2D1A
|
[NCBI]
|
8.16599e-06
|
|
|
FTCD
|
[NCBI]
|
8.16034e-06
|
|
|
MYO15A
|
[NCBI]
|
8.16034e-06
|
|
|
GAD1
|
[NCBI]
|
8.16034e-06
|
|
|
PITX3
|
[NCBI]
|
8.16034e-06
|
|
|
SLC6A2
|
[NCBI]
|
8.16034e-06
|
|
|
IGHMBP2
|
[NCBI]
|
8.16034e-06
|
|
|
FLCN
|
[NCBI]
|
8.16034e-06
|
|
|
RAB7
|
[NCBI]
|
8.16034e-06
|
|
|
ECGF1
|
[NCBI]
|
8.16034e-06
|
|
|
SOST
|
[NCBI]
|
8.16034e-06
|
|
|
DGAT1
|
[NCBI]
|
8.16034e-06
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
8.16034e-06
|
|
|
MERTK
|
[NCBI]
|
8.16034e-06
|
|
|
IL12RB1
|
[NCBI]
|
8.16034e-06
|
|
|
MTM1
|
[NCBI]
|
8.05687e-06
|
|
|
HIDS
|
[NCBI]
|
8.00141e-06
|
|
|
HNA
|
[NCBI]
|
8.00141e-06
|
|
|
TTDP
|
[NCBI]
|
8.00141e-06
|
|
|
VWM
|
[NCBI]
|
8.00141e-06
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
8.00141e-06
|
|
|
PCLD
|
[NCBI]
|
8.00141e-06
|
|
|
bethlem myopathy
|
[NCBI]
|
8.00141e-06
|
|
|
apc gene
|
[NCBI]
|
7.91904e-06
|
|
|
GALT
|
[NCBI]
|
7.82395e-06
|
|
|
RLBP1
|
[NCBI]
|
7.82395e-06
|
|
|
plasmin inhibitor deficiency
|
[NCBI]
|
7.71754e-06
|
|
|
ATP2A1
|
[NCBI]
|
7.71754e-06
|
|
|
SALL4
|
[NCBI]
|
7.71754e-06
|
|
|
MID1
|
[NCBI]
|
7.71754e-06
|
|
|
SIX1
|
[NCBI]
|
7.71754e-06
|
|
|
NPC2
|
[NCBI]
|
7.71754e-06
|
|
|
GALNT3
|
[NCBI]
|
7.71754e-06
|
|
|
GNAQ
|
[NCBI]
|
7.71754e-06
|
|
|
OCRL
|
[NCBI]
|
7.71754e-06
|
|
|
CRYGC
|
[NCBI]
|
7.71754e-06
|
|
|
SGCD
|
[NCBI]
|
7.71754e-06
|
|
|
ZAP70
|
[NCBI]
|
7.71754e-06
|
|
|
CHRNB2
|
[NCBI]
|
7.71754e-06
|
|
|
GFI1
|
[NCBI]
|
7.71754e-06
|
|
|
RPGRIP1
|
[NCBI]
|
7.71754e-06
|
|
|
TREX1
|
[NCBI]
|
7.71754e-06
|
|
|
NDRG1
|
[NCBI]
|
7.71754e-06
|
|
|
ICAM5
|
[NCBI]
|
7.71754e-06
|
|
|
hurler syndrome
|
[NCBI]
|
7.67269e-06
|
|
|
PMD
|
[NCBI]
|
7.63187e-06
|
|
|
OTC
|
[NCBI]
|
7.49825e-06
|
|
|
KIT
|
[NCBI]
|
7.49825e-06
|
|
|
PLP1
|
[NCBI]
|
7.34117e-06
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
7.32573e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
7.32573e-06
|
|
|
PMC
|
[NCBI]
|
7.32573e-06
|
|
|
PARK8
|
[NCBI]
|
7.32573e-06
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
7.32573e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
7.32573e-06
|
|
|
MED12
|
[NCBI]
|
7.31299e-06
|
|
|
XRCC2
|
[NCBI]
|
7.31299e-06
|
|
|
GARS
|
[NCBI]
|
7.31299e-06
|
|
|
CDX2
|
[NCBI]
|
7.31299e-06
|
|
|
SFTPC
|
[NCBI]
|
7.31299e-06
|
|
|
TCIRG1
|
[NCBI]
|
7.31299e-06
|
|
|
FLNB
|
[NCBI]
|
7.31299e-06
|
|
|
GABRA1
|
[NCBI]
|
7.31299e-06
|
|
|
RASSF1
|
[NCBI]
|
7.31299e-06
|
|
|
OLR1
|
[NCBI]
|
7.31299e-06
|
|
|
alsin
|
[NCBI]
|
7.31299e-06
|
|
|
HLCS
|
[NCBI]
|
7.31299e-06
|
|
|
COL9A1
|
[NCBI]
|
7.31299e-06
|
|
|
MAT1A
|
[NCBI]
|
7.31299e-06
|
|
|
TPM1
|
[NCBI]
|
7.31299e-06
|
|
|
KRT9
|
[NCBI]
|
7.31299e-06
|
|
|
ACAT1
|
[NCBI]
|
7.31299e-06
|
|
|
KCNJ1
|
[NCBI]
|
7.31299e-06
|
|
|
ABCB4
|
[NCBI]
|
7.31299e-06
|
|
|
WNK4
|
[NCBI]
|
7.31299e-06
|
|
|
SLS
|
[NCBI]
|
7.3028e-06
|
|
|
GNRHR
|
[NCBI]
|
7.18775e-06
|
|
|
SLC2A2
|
[NCBI]
|
7.03786e-06
|
|
|
BPES
|
[NCBI]
|
6.94665e-06
|
|
|
SLC25A1
|
[NCBI]
|
6.94123e-06
|
|
|
SUMO1
|
[NCBI]
|
6.94123e-06
|
|
|
TNNI3
|
[NCBI]
|
6.94123e-06
|
|
|
DNAH11
|
[NCBI]
|
6.94123e-06
|
|
|
POLH
|
[NCBI]
|
6.94123e-06
|
|
|
EFNB1
|
[NCBI]
|
6.94123e-06
|
|
|
OGG1
|
[NCBI]
|
6.94123e-06
|
|
|
DCTN1
|
[NCBI]
|
6.94123e-06
|
|
|
AGTR2
|
[NCBI]
|
6.94123e-06
|
|
|
SMOH
|
[NCBI]
|
6.94123e-06
|
|
|
CRYGD
|
[NCBI]
|
6.94123e-06
|
|
|
RHAG
|
[NCBI]
|
6.94123e-06
|
|
|
PRX
|
[NCBI]
|
6.94123e-06
|
|
|
CACNA1F
|
[NCBI]
|
6.94123e-06
|
|
|
MTMR2
|
[NCBI]
|
6.94123e-06
|
|
|
SMS
|
[NCBI]
|
6.9094e-06
|
|
|
HBD
|
[NCBI]
|
6.8914e-06
|
|
|
CDH1
|
[NCBI]
|
6.74825e-06
|
|
|
PGK1
|
[NCBI]
|
6.74825e-06
|
|
|
NHS
|
[NCBI]
|
6.70285e-06
|
|
|
CGL2
|
[NCBI]
|
6.70285e-06
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
6.70285e-06
|
|
|
CCAL2
|
[NCBI]
|
6.70285e-06
|
|
|
histidinemia
|
[NCBI]
|
6.70285e-06
|
|
|
EBR1
|
[NCBI]
|
6.70285e-06
|
|
|
ATM
|
[NCBI]
|
6.6687e-06
|
|
|
CFH
|
[NCBI]
|
6.6687e-06
|
|
|
NOS3
|
[NCBI]
|
6.60829e-06
|
|
|
PKD2
|
[NCBI]
|
6.60829e-06
|
|
|
SIX5
|
[NCBI]
|
6.59787e-06
|
|
|
TMPO
|
[NCBI]
|
6.59787e-06
|
|
|
POMT1
|
[NCBI]
|
6.59787e-06
|
|
|
AP3B1
|
[NCBI]
|
6.59787e-06
|
|
|
OTOF
|
[NCBI]
|
6.59787e-06
|
|
|
LIG4
|
[NCBI]
|
6.59787e-06
|
|
|
TNFRSF11A
|
[NCBI]
|
6.59787e-06
|
|
|
MMP13
|
[NCBI]
|
6.59787e-06
|
|
|
HPSE
|
[NCBI]
|
6.59787e-06
|
|
|
PFC
|
[NCBI]
|
6.59787e-06
|
|
|
TULP1
|
[NCBI]
|
6.59787e-06
|
|
|
CCKAR
|
[NCBI]
|
6.59787e-06
|
|
|
CTNS
|
[NCBI]
|
6.59787e-06
|
|
|
RAB27A
|
[NCBI]
|
6.59787e-06
|
|
|
AGL
|
[NCBI]
|
6.59787e-06
|
|
|
COCH
|
[NCBI]
|
6.59787e-06
|
|
|
SLC26A3
|
[NCBI]
|
6.59787e-06
|
|
|
ACTB
|
[NCBI]
|
6.59787e-06
|
|
|
oncogene dj1
|
[NCBI]
|
6.59787e-06
|
|
|
PKD1
|
[NCBI]
|
6.57593e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
6.56431e-06
|
|
|
STAT3
|
[NCBI]
|
6.55265e-06
|
|
|
IP
|
[NCBI]
|
6.32674e-06
|
|
|
PANK2
|
[NCBI]
|
6.27934e-06
|
|
|
SGCA
|
[NCBI]
|
6.27934e-06
|
|
|
LHX3
|
[NCBI]
|
6.27934e-06
|
|
|
SLC26A2
|
[NCBI]
|
6.27934e-06
|
|
|
LAMP2
|
[NCBI]
|
6.27934e-06
|
|
|
CRYBB2
|
[NCBI]
|
6.27934e-06
|
|
|
LYST
|
[NCBI]
|
6.27934e-06
|
|
|
GJD2
|
[NCBI]
|
6.27934e-06
|
|
|
CYBA
|
[NCBI]
|
6.27934e-06
|
|
|
PIK3CG
|
[NCBI]
|
6.27934e-06
|
|
|
GABRB3
|
[NCBI]
|
6.27934e-06
|
|
|
SCN9A
|
[NCBI]
|
6.27934e-06
|
|
|
SLC19A1
|
[NCBI]
|
6.27934e-06
|
|
|
donohue syndrome
|
[NCBI]
|
6.12774e-06
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
6.12774e-06
|
|
|
MDC1A
|
[NCBI]
|
6.12774e-06
|
|
|
sialuria, finnish type
|
[NCBI]
|
6.12774e-06
|
|
|
PPH1
|
[NCBI]
|
6.12774e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
6.12774e-06
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
6.12774e-06
|
|
|
CDKN2A
|
[NCBI]
|
6.04362e-06
|
|
|
RASA1
|
[NCBI]
|
6.03415e-06
|
|
|
GABRG2
|
[NCBI]
|
5.98273e-06
|
|
|
MYO6
|
[NCBI]
|
5.98273e-06
|
|
|
MEF2A
|
[NCBI]
|
5.98273e-06
|
|
|
SLC16A2
|
[NCBI]
|
5.98273e-06
|
|
|
TBX1
|
[NCBI]
|
5.98273e-06
|
|
|
CAST
|
[NCBI]
|
5.98273e-06
|
|
|
DLL3
|
[NCBI]
|
5.98273e-06
|
|
|
RNASEL
|
[NCBI]
|
5.98273e-06
|
|
|
ROR2
|
[NCBI]
|
5.98273e-06
|
|
|
IL7R
|
[NCBI]
|
5.98273e-06
|
|
|
TAZ
|
[NCBI]
|
5.98273e-06
|
|
|
SCNN1B
|
[NCBI]
|
5.98273e-06
|
|
|
C7
|
[NCBI]
|
5.98273e-06
|
|
|
NSD1
|
[NCBI]
|
5.98273e-06
|
|
|
GJA4
|
[NCBI]
|
5.98273e-06
|
|
|
RDT
|
[NCBI]
|
5.95591e-06
|
|
|
PMP22
|
[NCBI]
|
5.91269e-06
|
|
|
SOD1
|
[NCBI]
|
5.8682e-06
|
|
|
GCCR
|
[NCBI]
|
5.83033e-06
|
|
|
DGS
|
[NCBI]
|
5.80688e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
5.76003e-06
|
|
|
CTNNB1
|
[NCBI]
|
5.71015e-06
|
|
|
SURF1
|
[NCBI]
|
5.7056e-06
|
|
|
UCHL1
|
[NCBI]
|
5.7056e-06
|
|
|
ACADVL
|
[NCBI]
|
5.7056e-06
|
|
|
CBP
|
[NCBI]
|
5.7056e-06
|
|
|
HSD17B4
|
[NCBI]
|
5.7056e-06
|
|
|
SPG7
|
[NCBI]
|
5.7056e-06
|
|
|
PTS
|
[NCBI]
|
5.7056e-06
|
|
|
SQSTM1
|
[NCBI]
|
5.7056e-06
|
|
|
ACY1
|
[NCBI]
|
5.7056e-06
|
|
|
USH1C
|
[NCBI]
|
5.7056e-06
|
|
|
TSHB
|
[NCBI]
|
5.7056e-06
|
|
|
SCZD
|
[NCBI]
|
5.60751e-06
|
|
|
MSD
|
[NCBI]
|
5.59604e-06
|
|
|
CHNG2
|
[NCBI]
|
5.59604e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
5.59604e-06
|
|
|
TGD
|
[NCBI]
|
5.59604e-06
|
|
|
diastrophic dysplasia
|
[NCBI]
|
5.59604e-06
|
|
|
LCAT
|
[NCBI]
|
5.56117e-06
|
|
|
SHH
|
[NCBI]
|
5.54216e-06
|
|
|
ANG
|
[NCBI]
|
5.47723e-06
|
|
|
AQP2
|
[NCBI]
|
5.47723e-06
|
|
|
ABCD1
|
[NCBI]
|
5.47723e-06
|
|
|
SLC6A4
|
[NCBI]
|
5.45324e-06
|
|
|
ACTC1
|
[NCBI]
|
5.44588e-06
|
|
|
MUTYH
|
[NCBI]
|
5.44588e-06
|
|
|
PER2
|
[NCBI]
|
5.44588e-06
|
|
|
AOF2
|
[NCBI]
|
5.44588e-06
|
|
|
PCDH15
|
[NCBI]
|
5.44588e-06
|
|
|
PQBP1
|
[NCBI]
|
5.44588e-06
|
|
|
ADRB3
|
[NCBI]
|
5.44588e-06
|
|
|
SPR
|
[NCBI]
|
5.44588e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
5.44588e-06
|
|
|
GUCY2D
|
[NCBI]
|
5.44588e-06
|
|
|
COL11A2
|
[NCBI]
|
5.44588e-06
|
|
|
KCNE1
|
[NCBI]
|
5.44588e-06
|
|
|
PCCB
|
[NCBI]
|
5.44588e-06
|
|
|
KRIT1
|
[NCBI]
|
5.44588e-06
|
|
|
FAAH
|
[NCBI]
|
5.28682e-06
|
|
|
RAG2
|
[NCBI]
|
5.20185e-06
|
|
|
WNK1
|
[NCBI]
|
5.20185e-06
|
|
|
CHRNA4
|
[NCBI]
|
5.20185e-06
|
|
|
SN
|
[NCBI]
|
5.20185e-06
|
|
|
AMELX
|
[NCBI]
|
5.20185e-06
|
|
|
NEB
|
[NCBI]
|
5.20185e-06
|
|
|
SMAD2
|
[NCBI]
|
5.20185e-06
|
|
|
ERCC6
|
[NCBI]
|
5.20185e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
5.20185e-06
|
|
|
NR0B2
|
[NCBI]
|
5.1454e-06
|
|
|
VCP
|
[NCBI]
|
5.1454e-06
|
|
|
CRMO
|
[NCBI]
|
5.10398e-06
|
|
|
hyperglycerolemia
|
[NCBI]
|
5.10398e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
5.10398e-06
|
|
|
HGPS
|
[NCBI]
|
5.07259e-06
|
|
|
TD1
|
[NCBI]
|
5.07259e-06
|
|
|
LRRK2
|
[NCBI]
|
5.03922e-06
|
|
|
NRL
|
[NCBI]
|
4.97199e-06
|
|
|
EIF5A
|
[NCBI]
|
4.97199e-06
|
|
|
CHRNA1
|
[NCBI]
|
4.97199e-06
|
|
|
TNXB
|
[NCBI]
|
4.97199e-06
|
|
|
CPT2
|
[NCBI]
|
4.97199e-06
|
|
|
FLT3
|
[NCBI]
|
4.97199e-06
|
|
|
DCX
|
[NCBI]
|
4.97199e-06
|
|
|
PEX7
|
[NCBI]
|
4.97199e-06
|
|
|
PYGM
|
[NCBI]
|
4.97199e-06
|
|
|
TBX5
|
[NCBI]
|
4.97199e-06
|
|
|
MYH6
|
[NCBI]
|
4.97199e-06
|
|
|
TLR4
|
[NCBI]
|
4.93946e-06
|
|
|
PARK2
|
[NCBI]
|
4.83314e-06
|
|
|
SLC5A5
|
[NCBI]
|
4.75503e-06
|
|
|
GHRHR
|
[NCBI]
|
4.75503e-06
|
|
|
FOXC2
|
[NCBI]
|
4.75503e-06
|
|
|
F12
|
[NCBI]
|
4.75503e-06
|
|
|
ATP2A2
|
[NCBI]
|
4.75503e-06
|
|
|
PNKD1
|
[NCBI]
|
4.64826e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
4.64826e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
4.64826e-06
|
|
|
PAX8
|
[NCBI]
|
4.54984e-06
|
|
|
GATA3
|
[NCBI]
|
4.54984e-06
|
|
|
RHD
|
[NCBI]
|
4.54984e-06
|
|
|
RPE65
|
[NCBI]
|
4.54984e-06
|
|
|
DLD
|
[NCBI]
|
4.54984e-06
|
|
|
MRE11A
|
[NCBI]
|
4.54984e-06
|
|
|
GIST
|
[NCBI]
|
4.52456e-06
|
|
|
DBA
|
[NCBI]
|
4.50515e-06
|
|
|
HMBS
|
[NCBI]
|
4.40065e-06
|
|
|
HP
|
[NCBI]
|
4.36937e-06
|
|
|
MAP2K1
|
[NCBI]
|
4.35543e-06
|
|
|
COL4A1
|
[NCBI]
|
4.35543e-06
|
|
|
CDH23
|
[NCBI]
|
4.35543e-06
|
|
|
EDA
|
[NCBI]
|
4.35543e-06
|
|
|
MTND3
|
[NCBI]
|
4.35543e-06
|
|
|
CYP11B1
|
[NCBI]
|
4.35543e-06
|
|
|
BIRC5
|
[NCBI]
|
4.35543e-06
|
|
|
ABCB1
|
[NCBI]
|
4.33598e-06
|
|
|
factor v deficiency
|
[NCBI]
|
4.26155e-06
|
|
|
FTD
|
[NCBI]
|
4.24568e-06
|
|
|
DYX1
|
[NCBI]
|
4.22595e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
4.22595e-06
|
|
|
pheochromocytoma
|
[NCBI]
|
4.22595e-06
|
|
|
SMA2
|
[NCBI]
|
4.22595e-06
|
|
|
osteoarthritis
|
[NCBI]
|
4.22595e-06
|
|
|
MYO5A
|
[NCBI]
|
4.17095e-06
|
|
|
TGM1
|
[NCBI]
|
4.17095e-06
|
|
|
SLC12A3
|
[NCBI]
|
4.17095e-06
|
|
|
SRF
|
[NCBI]
|
4.11674e-06
|
|
|
ASS
|
[NCBI]
|
3.99968e-06
|
|
|
NR1I2
|
[NCBI]
|
3.99677e-06
|
|
|
KCNA1
|
[NCBI]
|
3.99563e-06
|
|
|
TTR
|
[NCBI]
|
3.92299e-06
|
|
|
WHS
|
[NCBI]
|
3.83464e-06
|
|
|
OPTB1
|
[NCBI]
|
3.8345e-06
|
|
|
DFNB1
|
[NCBI]
|
3.8345e-06
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
3.8345e-06
|
|
|
COL4A3
|
[NCBI]
|
3.82879e-06
|
|
|
AICDA
|
[NCBI]
|
3.66983e-06
|
|
|
CHRNE
|
[NCBI]
|
3.66983e-06
|
|
|
CD8A
|
[NCBI]
|
3.66983e-06
|
|
|
PPIB
|
[NCBI]
|
3.66983e-06
|
|
|
ITGA2B
|
[NCBI]
|
3.66983e-06
|
|
|
KL
|
[NCBI]
|
3.66983e-06
|
|
|
IFNGR1
|
[NCBI]
|
3.66983e-06
|
|
|
PROP1
|
[NCBI]
|
3.66983e-06
|
|
|
PTCH1
|
[NCBI]
|
3.66983e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
3.51847e-06
|
|
|
TNFRSF1A
|
[NCBI]
|
3.51847e-06
|
|
|
LFNG
|
[NCBI]
|
3.51819e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
3.51819e-06
|
|
|
PITX2
|
[NCBI]
|
3.51819e-06
|
|
|
SLC22A6
|
[NCBI]
|
3.51819e-06
|
|
|
C1NH
|
[NCBI]
|
3.51819e-06
|
|
|
COL17A1
|
[NCBI]
|
3.51819e-06
|
|
|
neural tube defects
|
[NCBI]
|
3.47162e-06
|
|
|
PPSH
|
[NCBI]
|
3.47162e-06
|
|
|
POF1
|
[NCBI]
|
3.47162e-06
|
|
|
DAR
|
[NCBI]
|
3.47162e-06
|
|
|
G6PD
|
[NCBI]
|
3.44961e-06
|
|
|
AMH
|
[NCBI]
|
3.44027e-06
|
|
|
FRAP1
|
[NCBI]
|
3.41588e-06
|
|
|
GP1BA
|
[NCBI]
|
3.3734e-06
|
|
|
XPC
|
[NCBI]
|
3.3734e-06
|
|
|
DHH
|
[NCBI]
|
3.3734e-06
|
|
|
PROS1
|
[NCBI]
|
3.3734e-06
|
|
|
HGFAC
|
[NCBI]
|
3.23501e-06
|
|
|
RBP4
|
[NCBI]
|
3.23501e-06
|
|
|
APOH
|
[NCBI]
|
3.23501e-06
|
|
|
GPC3
|
[NCBI]
|
3.23501e-06
|
|
|
CSTB
|
[NCBI]
|
3.23501e-06
|
|
|
MSH6
|
[NCBI]
|
3.23501e-06
|
|
|
CYP11B2
|
[NCBI]
|
3.23501e-06
|
|
|
TWIST1
|
[NCBI]
|
3.23501e-06
|
|
|
RTN4R
|
[NCBI]
|
3.23501e-06
|
|
|
EDN3
|
[NCBI]
|
3.23501e-06
|
|
|
ATRX
|
[NCBI]
|
3.13526e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.10263e-06
|
|
|
COL6A1
|
[NCBI]
|
3.10263e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
3.10263e-06
|
|
|
SMAD4
|
[NCBI]
|
3.10263e-06
|
|
|
MTRNR1
|
[NCBI]
|
3.10263e-06
|
|
|
CPE
|
[NCBI]
|
3.08798e-06
|
|
|
LEPR
|
[NCBI]
|
3.02073e-06
|
|
|
ENPP1
|
[NCBI]
|
2.97587e-06
|
|
|
BANF1
|
[NCBI]
|
2.97587e-06
|
|
|
TNFRSF14
|
[NCBI]
|
2.97587e-06
|
|
|
MTND6
|
[NCBI]
|
2.97587e-06
|
|
|
oca2 gene
|
[NCBI]
|
2.97587e-06
|
|
|
SERPINA6
|
[NCBI]
|
2.96791e-06
|
|
|
ABCB11
|
[NCBI]
|
2.95469e-06
|
|
|
DNMT3B
|
[NCBI]
|
2.85443e-06
|
|
|
CLCN1
|
[NCBI]
|
2.85443e-06
|
|
|
CYBB
|
[NCBI]
|
2.85443e-06
|
|
|
POU1F1
|
[NCBI]
|
2.85443e-06
|
|
|
GH1
|
[NCBI]
|
2.82616e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
2.82359e-06
|
|
|
DKC
|
[NCBI]
|
2.82359e-06
|
|
|
HHC1
|
[NCBI]
|
2.82359e-06
|
|
|
VDR
|
[NCBI]
|
2.81694e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
2.78172e-06
|
|
|
GLB1
|
[NCBI]
|
2.73798e-06
|
|
|
IKBKG
|
[NCBI]
|
2.73798e-06
|
|
|
PEPD
|
[NCBI]
|
2.73798e-06
|
|
|
NBS1
|
[NCBI]
|
2.73798e-06
|
|
|
CBD
|
[NCBI]
|
2.73798e-06
|
|
|
CDK6
|
[NCBI]
|
2.73798e-06
|
|
|
IDE
|
[NCBI]
|
2.7022e-06
|
|
|
AKR1B1
|
[NCBI]
|
2.66378e-06
|
|
|
SLAMF1
|
[NCBI]
|
2.62626e-06
|
|
|
ICAM1
|
[NCBI]
|
2.62626e-06
|
|
|
IL13
|
[NCBI]
|
2.62626e-06
|
|
|
MTCO2
|
[NCBI]
|
2.62626e-06
|
|
|
GHRL
|
[NCBI]
|
2.62626e-06
|
|
|
CXCR4
|
[NCBI]
|
2.62626e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.62626e-06
|
|
|
HEMB
|
[NCBI]
|
2.58551e-06
|
|
|
CDK4
|
[NCBI]
|
2.54258e-06
|
|
|
RBS
|
[NCBI]
|
2.53497e-06
|
|
|
NDP
|
[NCBI]
|
2.51901e-06
|
|
|
FGF10
|
[NCBI]
|
2.51901e-06
|
|
|
MDM2
|
[NCBI]
|
2.51901e-06
|
|
|
MYO7A
|
[NCBI]
|
2.51901e-06
|
|
|
NTRK2
|
[NCBI]
|
2.51901e-06
|
|
|
GHRH
|
[NCBI]
|
2.41609e-06
|
|
|
ACADS
|
[NCBI]
|
2.41599e-06
|
|
|
FANCA
|
[NCBI]
|
2.41599e-06
|
|
|
ADRP
|
[NCBI]
|
2.41599e-06
|
|
|
MTCO1
|
[NCBI]
|
2.41599e-06
|
|
|
HBA1
|
[NCBI]
|
2.4156e-06
|
|
|
PEMT
|
[NCBI]
|
2.31698e-06
|
|
|
FANCC
|
[NCBI]
|
2.31698e-06
|
|
|
TPI1
|
[NCBI]
|
2.31698e-06
|
|
|
PPT1
|
[NCBI]
|
2.2218e-06
|
|
|
EDNRB
|
[NCBI]
|
2.2218e-06
|
|
|
GNMT
|
[NCBI]
|
2.13024e-06
|
|
|
SMN2
|
[NCBI]
|
2.13024e-06
|
|
|
UMOD
|
[NCBI]
|
2.13024e-06
|
|
|
FY
|
[NCBI]
|
2.13024e-06
|
|
|
fucosidosis
|
[NCBI]
|
2.13024e-06
|
|
|
HIF1A
|
[NCBI]
|
2.04213e-06
|
|
|
ILK
|
[NCBI]
|
1.86503e-06
|
|
|
CGD
|
[NCBI]
|
1.80788e-06
|
|
|
HPRT1
|
[NCBI]
|
1.76671e-06
|
|
|
KAL1
|
[NCBI]
|
1.72122e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
1.72122e-06
|
|
|
RUNX1
|
[NCBI]
|
1.72122e-06
|
|
|
RELN
|
[NCBI]
|
1.6482e-06
|
|
|
SJS1
|
[NCBI]
|
1.58321e-06
|
|
|
meningioma, familial
|
[NCBI]
|
1.58321e-06
|
|
|
OCA2
|
[NCBI]
|
1.58321e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.58321e-06
|
|
|
sandhoff disease
|
[NCBI]
|
1.58321e-06
|
|
|
ERBB2
|
[NCBI]
|
1.57781e-06
|
|
|
WRN
|
[NCBI]
|
1.53761e-06
|
|
|
ALAD
|
[NCBI]
|
1.50994e-06
|
|
|
von willebrand disease
|
[NCBI]
|
1.47774e-06
|
|
|
IGFALS
|
[NCBI]
|
1.43941e-06
|
|
|
DMD
|
[NCBI]
|
1.42448e-06
|
|
|
GJA1
|
[NCBI]
|
1.42321e-06
|
|
|
kartagener syndrome
|
[NCBI]
|
1.39006e-06
|
|
|
SMA3
|
[NCBI]
|
1.39006e-06
|
|
|
GCPS
|
[NCBI]
|
1.39006e-06
|
|
|
HS
|
[NCBI]
|
1.32056e-06
|
|
|
GRP
|
[NCBI]
|
1.27831e-06
|
|
|
EPOR
|
[NCBI]
|
1.27831e-06
|
|
|
MTND1
|
[NCBI]
|
1.26187e-06
|
|
|
PSAP
|
[NCBI]
|
1.26187e-06
|
|
|
LDLR
|
[NCBI]
|
1.23308e-06
|
|
|
neuraminidase deficiency
|
[NCBI]
|
1.21283e-06
|
|
|
PROCR
|
[NCBI]
|
1.15064e-06
|
|
|
ABL1
|
[NCBI]
|
1.15064e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
1.12349e-06
|
|
|
breast cancer
|
[NCBI]
|
1.12349e-06
|
|
|
INSL3
|
[NCBI]
|
1.09796e-06
|
|
|
TFRC
|
[NCBI]
|
1.09796e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
1.05065e-06
|
|
|
STAR
|
[NCBI]
|
1.03116e-06
|
|
|
SDS
|
[NCBI]
|
1.02221e-06
|
|
|
DRD2
|
[NCBI]
|
9.98131e-07
|
|
|
F2
|
[NCBI]
|
9.98131e-07
|
|
|
alopecia, androgenetic
|
[NCBI]
|
9.24856e-07
|
|
|
TRPS2
|
[NCBI]
|
9.02727e-07
|
|
|
IGF1
|
[NCBI]
|
8.61292e-07
|
|
|
ASL
|
[NCBI]
|
8.61292e-07
|
|
|
SLC11A1
|
[NCBI]
|
8.61292e-07
|
|
|
IBD1
|
[NCBI]
|
8.31537e-07
|
|
|
KRAS
|
[NCBI]
|
8.18896e-07
|
|
|
MTND4
|
[NCBI]
|
8.18896e-07
|
|
|
HRAS
|
[NCBI]
|
8.18896e-07
|
|
|
ITGB3
|
[NCBI]
|
7.78025e-07
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
7.78025e-07
|
|
|
BCHE
|
[NCBI]
|
7.73423e-07
|
|
|
POAG
|
[NCBI]
|
7.68335e-07
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
7.68335e-07
|
|
|
TG
|
[NCBI]
|
7.65842e-07
|
|
|
STAT5A
|
[NCBI]
|
7.57367e-07
|
|
|
AT
|
[NCBI]
|
7.46923e-07
|
|
|
MMP2
|
[NCBI]
|
7.38629e-07
|
|
|
GPI
|
[NCBI]
|
7.12569e-07
|
|
|
IRS1
|
[NCBI]
|
7.00664e-07
|
|
|
BTC
|
[NCBI]
|
7.00664e-07
|
|
|
KITLG
|
[NCBI]
|
6.91758e-07
|
|
|
FOXP3
|
[NCBI]
|
6.64086e-07
|
|
|
JAK3
|
[NCBI]
|
6.64086e-07
|
|
|
asthma, susceptibility to
|
[NCBI]
|
6.57483e-07
|
|
|
AVSD
|
[NCBI]
|
6.57483e-07
|
|
|
hypertension, essential
|
[NCBI]
|
6.57483e-07
|
|
|
COMT
|
[NCBI]
|
6.51669e-07
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
6.46795e-07
|
|
|
NOTCH1
|
[NCBI]
|
6.28854e-07
|
|
|
APS1
|
[NCBI]
|
6.28329e-07
|
|
|
AR
|
[NCBI]
|
6.24003e-07
|
|
|
menkes disease
|
[NCBI]
|
5.76996e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
5.6227e-07
|
|
|
HSAN3
|
[NCBI]
|
5.3748e-07
|
|
|
HAE
|
[NCBI]
|
5.3748e-07
|
|
|
MCP
|
[NCBI]
|
5.34849e-07
|
|
|
DSPP
|
[NCBI]
|
5.30844e-07
|
|
|
APOB
|
[NCBI]
|
4.75366e-07
|
|
|
TERT
|
[NCBI]
|
4.75082e-07
|
|
|
LEP
|
[NCBI]
|
4.58446e-07
|
|
|
RTS
|
[NCBI]
|
4.39809e-07
|
|
|
XPA
|
[NCBI]
|
4.39809e-07
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
4.29773e-07
|
|
|
FSHR
|
[NCBI]
|
4.1679e-07
|
|
|
PCD
|
[NCBI]
|
3.89243e-07
|
|
|
VASP
|
[NCBI]
|
3.78792e-07
|
|
|
FFI
|
[NCBI]
|
3.64558e-07
|
|
|
DM2
|
[NCBI]
|
3.53239e-07
|
|
|
EDMD
|
[NCBI]
|
3.53239e-07
|
|
|
GHR
|
[NCBI]
|
3.1422e-07
|
|
|
BMP2
|
[NCBI]
|
2.98176e-07
|
|
|
AGER
|
[NCBI]
|
2.91375e-07
|
|
|
IAPP
|
[NCBI]
|
2.82227e-07
|
|
|
MTTL1
|
[NCBI]
|
2.77378e-07
|
|
|
SLC11A2
|
[NCBI]
|
2.77378e-07
|
|
|
sotos syndrome
|
[NCBI]
|
2.77266e-07
|
|
|
ALGS1
|
[NCBI]
|
2.77266e-07
|
|
|
aortic valve disease
|
[NCBI]
|
2.77266e-07
|
|
|
UCP1
|
[NCBI]
|
2.51217e-07
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.45502e-07
|
|
|
MTR
|
[NCBI]
|
2.38514e-07
|
|
|
NIDDM
|
[NCBI]
|
1.94463e-07
|
|
|
CDK5
|
[NCBI]
|
1.88731e-07
|
|
|
PLN
|
[NCBI]
|
1.56305e-07
|
|
|
CSA
|
[NCBI]
|
1.5526e-07
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
1.5526e-07
|
|
|
IHH
|
[NCBI]
|
1.46945e-07
|
|
|
CHS
|
[NCBI]
|
1.22886e-07
|
|
|
ALPS
|
[NCBI]
|
1.09269e-07
|
|
|
TCOF
|
[NCBI]
|
1.09012e-07
|
|
|
glioma of brain, familial
|
[NCBI]
|
1.08374e-07
|
|
|
BTK
|
[NCBI]
|
1.04655e-07
|
|
|
HEXA
|
[NCBI]
|
9.356e-08
|
|
|
MITF
|
[NCBI]
|
7.41203e-08
|
|
|
HHT
|
[NCBI]
|
7.03763e-08
|
|
|
HNPP
|
[NCBI]
|
7.03763e-08
|
|
|
GRA
|
[NCBI]
|
7.03763e-08
|
|
|
CCND1
|
[NCBI]
|
5.95567e-08
|
|
|
ALD
|
[NCBI]
|
4.98749e-08
|
|
|
maple syrup urine disease
|
[NCBI]
|
4.09037e-08
|
|
|
CCM
|
[NCBI]
|
4.09037e-08
|
|
|
MHS1
|
[NCBI]
|
4.09037e-08
|
|
|
HHF2
|
[NCBI]
|
4.09037e-08
|
|
|
AN2
|
[NCBI]
|
4.09037e-08
|
|
|
RB1
|
[NCBI]
|
3.67844e-08
|
|
|
ACH
|
[NCBI]
|
3.38601e-08
|
|
|
TS
|
[NCBI]
|
2.51028e-08
|
|
|
CLS
|
[NCBI]
|
1.96155e-08
|
|
|
PLG
|
[NCBI]
|
1.39287e-08
|
|
|
COL1A1
|
[NCBI]
|
1.28503e-08
|
|
|
NSF
|
[NCBI]
|
1.07568e-08
|
|
|
CP
|
[NCBI]
|
9.2946e-09
|
|
|
PRNP
|
[NCBI]
|
8.09014e-09
|
|
|
RBP1
|
[NCBI]
|
4.67061e-09
|
|
|
GUSB
|
[NCBI]
|
3.09541e-09
|
|
|
LPL
|
[NCBI]
|
1.57323e-09
|
|
|
PIGR
|
[NCBI]
|
5.7986e-10
|
|
|
HDAC1
|
[NCBI]
|
5.08096e-10
|
|
|
NRG1
|
[NCBI]
|
5.03195e-11
|
|
|
FMR1
|
[NCBI]
|
8.84129e-13
|
|